PDB46 Direct Medical Costs of Treating Diabetes Related Complications in Mexico (Englisch)
- Neue Suche nach: Vega-Herná
- Neue Suche nach: ndez, G.
- Neue Suche nach: Jugrin, A.
- Neue Suche nach: Radford, M.
- Neue Suche nach: Bloomfield, E.
- Neue Suche nach: Todorova, L.
- Neue Suche nach: Hansen, B.
- Neue Suche nach: Vega-Herná
- Neue Suche nach: ndez, G.
- Neue Suche nach: Jugrin, A.
- Neue Suche nach: Radford, M.
- Neue Suche nach: Bloomfield, E.
- Neue Suche nach: Todorova, L.
- Neue Suche nach: Hansen, B.
In:
VALUE IN HEALTH
;
15
, 4
;
A178-A179
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PDB46 Direct Medical Costs of Treating Diabetes Related Complications in Mexico
-
Beteiligte:Vega-Herná ( Autor:in ) / ndez, G. ( Autor:in ) / Jugrin, A. ( Autor:in ) / Radford, M. ( Autor:in ) / Bloomfield, E. ( Autor:in ) / Todorova, L. ( Autor:in ) / Hansen, B. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 15, 4 ; A178-A179
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2012
-
Format / Umfang:A178-A179
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 15, Ausgabe 4
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A2
-
ME2 Effect of Medicare Prescription Drug Program (Part D) on Medication Adherence for Dual Eligibles: Case of ACEIs and ARBsKim, J. A. / Park, T. et al. | 2012
- A3
-
RM3 Antipsychotic Use and Risk of All-Cause Mortality in Elderly Dual Eligible BeneficiariesAparasu, R. R. / Chatterjee, S. / Mehta, S. / Chen, H. et al. | 2012
- A4
-
SB4 Propensity-Score Matching (PSM) to Control for Selection Bias in “Real-World” Treatment Comparisons: A Cautionary Tale Concerning Antibiotic Therapy for Infectious DiseaseBerger, A. / Mckinnon, P. S. / Larson, K. / Crompton, M. / Hennegan, K. / Weber, D. J. / Boening, A. J. / Oster, G. et al. | 2012
- A5
-
CV1 Differences in Processes and Outcomes of Care in Elderly Hypertensive Diabetic Patients With and Without DementiaChitnis, A. S. / Johnson, M. L. et al. | 2012
- A6
-
DR2 The Relationship Between Pseudoephedrine Sales and Clandestine Methamphetamine LabsTalbert, J. / Blumenschein, K. / Freeman, P. R. et al. | 2012
- A10
-
PR1 FDA Actions Against Health Economic Promotions, 2002-2011Neumann, P. J. / Bliss, S. et al. | 2012
- A11
-
QU2 Cross-Cultural Psychometric Evaluation of the Ensemble MDSBushnell, D. M. / Mccarrier, K. P. / Martin, M. L. / Paczkowski, R. / Shen, W. / Buesching, D. et al. | 2012
- A14
-
PHP10 Australia's Rule of Rescue and the Life Saving Drugs Programme: Same-Same But Different?Priest, V. L. / Dummett, H. et al. | 2012
- A15
-
PHP15 What Price do we Pay for Repurposing Medicines for Rare Diseases?Simoens, S. / Picavet, E. / Cassiman, D. / Dooms, M. et al. | 2012
- A16
-
PHP21 Complementary and Alternative Medicine Use Among People With Disabilities: NHIS 2007 SurveyVohra, R. / Pan, X. L. / Sambamoorthi, U. et al. | 2012
- A17
-
PHP26 Multimorbidity and PolypharmacyVyas, A. / Pan, X. L. / Sambamoorthi, U. et al. | 2012
- A19
-
PHP38 Out-of-Pocket Drug Expenditure Among Users of the Ambulatory Care Services at the Mexican Institute of Social Security (IMSS)Uc-Coyoc, R. / Pé / rez-Reynaud, A. G. / Coello-Reyes, L. A. / Rodriguez-Dí / az Ponce, M. A. et al. | 2012
- A21
-
PHP50 The Health and Economics Bulletin – an Analysis of Three Years of PublicationLima, S. O. / Calais, G. S. / Caldeira, T. R. / Garcia, G. C. / Gava, C. M. / Pereira, R. F. / Ronchini, M. A. / Troncoso, G. C. et al. | 2012
- A22
-
PHP55 Evidence Based Advertisement: Where is the Pharmacoeconomic and Humanistic Outcomes Research Evidence?Muragundi, P. M. / Chandu Sagar, N. / Aishwarya, K. / Udupa, N. / Naik, A. N. et al. | 2012
- A24
-
PHP66 Assessing Agreement Between Patient Access Schemes: Review of Nice and SMC GuidanceTimm, B. / Leonard, S. A. / Haynes, S. et al. | 2012
- A25
-
PHP71 Pharmacoeconomic Education in Schools and Colleges of Pharmacy in 2011 in the United StatesMakhinova, T. / Rascati, K. L. et al. | 2012
- A26
-
PHP77 Technological Intervention: Nurses' Perception Regarding Performance Obstacles and Ease of WorkHatfield, M. D. / Dwibedi, N. / Frost, C. P. / Sansgiry, S. S. et al. | 2012
- A27
-
PHP83 Community Health Workers: A Literature Review in Some Countries of South AmericaBorda-Olivas, A. / Palma-Ruiz, M. / Drasbek, C. / Sarria-Santamera, A. et al. | 2012
- A28
-
PHP88 National Patterns and Trends of Off-Label Use of Antipsychotic Medications in the Elderly Following FDA Black Box WarningsTeigland, C. / Jones, B. T. / Parente, A. K. / Wang, R. H. / Yin, S. et al. | 2012
- A29
-
PHP93 Impact of Prescription Monitoring Programs on Pharmacists' Controlled Substance Dispensing BehaviorWixson, S. E. / Talbert, J. / Blumenschein, K. / Freeman, P. R. et al. | 2012
- A31
-
PHP104 Potential Implications of National Disease Registries and Centers of Excellence for Orphan Diseases for Pharmaceutical Manufacturers Developing Orphan DrugsDobrovolny, D. / Patel, A. / Dalsania, R. / Paas, M. et al. | 2012
- A33
-
PMS3 Comparative Effectiveness Analysis Using “Real-World” Patient Database to Evaluate the Fractures Rates Comparing Annual Zoledronic Acid Infusion with Oral BisphosphonatesLian, J. / Song, X. / Varker, H. / Cao, Z. / Recknor, C. et al. | 2012
- A35
-
PMS14 Health Care Costs and Opioid Use among Patients with Osteoarthritis Initiating Duloxetine Versus Other TreatmentsHong, J. / Peng, X. / Andrews, J. S. / Novick, D. et al. | 2012
- A36
-
PMS19 Impact of Disease Severity on the Total, Health-Related, Financial Costs of Treatment of People with Rheumatoid Arthritis in the United KingdomPoole, C. D. / Currie, C. J. / Holden, S. / Singh, A. et al. | 2012
- A37
-
PMS24 Cost and Pattern of Motorcycle Accidents at a Tertiary Care Hospital in SindhKhowaja, M. A. et al. | 2012
- A38
-
PMS29 Cost-Effectiveness of Collagenase Clostridium Histolyticum, Limited Fasciectomy, and Percutaneous Needle Fasciotomy in the Treatment of Dupuytren's ContractureMalone, D. C. / Armstrong, E. P. et al. | 2012
- A39
-
PMS35 The Cost-Effectiveness of Pegloticase in the Treatment of Refractory Chronic GoutWang, B. C. / Garrison, L. et al. | 2012
- A42
-
PMS50 Benefits in Patient Reported Outcomes Supporting a “Treat to Target” Paradigm for Infliximab -Treated RA Patients Previously Inadequately Responsive to Prior Anti-TNF TreatmentIngham, M. / Tang, L. / Decktor, D. / Bolce, R. / Wang, J. et al. | 2012
- A43
-
PMS55 Quality of Life among Patients with Self-Reported Rheumatoid Arthritis: A Nationally Representative SampleRappaport, H. et al. | 2012
- A44
-
PMS60 Infliximab Therapy Improves the Quality of Life of Ankylosing Sporidylitis Patients in ChinaWang, N. S. / Bi, L. Q. / Chen, J. W. / He, D. Y. / Wu, L. J. / Lin, J. / Chang, J. H. / Li, J. G. / Feng, W. et al. | 2012
- A45
-
PMS66 Satisfaction with and Preference for Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients Switched from Adalimumab or EtanerceptTandon, N. / Bolce, R. / Naim, A. / Bolge, S. / Ellis, L. / Piech, C. T. / Decktor, D. et al. | 2012
- A46
-
PMS71 Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women in JapanMoriwaki, K. / Komaba, H. / Noto, S. / Yanagisawa, S. / Inoue, H. / Takeshi, T. / Fukagawa, M. / Takahashi, H. E. et al. | 2012
- A49
-
PMS87 Osteoarthritis in France the Cost of Ambulatory Care in 2010Taieb, C. et al. | 2012
- A50
-
PMS92 Adaptation and Validation of an Indian Version of the Health Related Quality of Life Scale (IND-HAQ) in Indian Patients with Rheumatoid ArthritisKhera, K. / Nagappa, A. N. / Balakrishnan, R. / Sharma, S. et al. | 2012
- A51
-
PRS3 Inhaled Anticholinergics and Risk of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta Analysis of Randomized Controlled TrialsAjmera, M. R. / Rane, P. B. / Kelley, G. / Sambamoorthi, U. et al. | 2012
- A52
-
PRS8 Evaluation of the Association Between Statin Use and Risk of Chronic Obstructive Pulmonary Disease ExacerbationWang, M. T. / Lo, Y. W. et al. | 2012
- A53
-
PRS14 Cost-Effectiveness of Azithromycin and Clarithromycin Treatments for Community Acquired Pneumonia Requiring Hospitalization for Immunocompetent Individuals of Age 65 and Older, from Private Perspective in BrazilFujii, R. K. / Mould, J. F. / Lanzara, G. D. / Manfrin, D. F. et al. | 2012
- A54
-
PRS19 Exacerbations and Costs in Chronic Bronchitis Patients Treated with Copd Medications from a Managed Care Population in the United StatesAbudagga, A. / Sun, S. X. / Tan, H. / Kavati, A. / Solem, C. T. / Botteman, M. F. et al. | 2012
- A55
-
PRS24 Cost-Effectiveness Analysis of Voriconazole, Amphotericin B and Caspofungin for Invasive Aspergilosis Patients in Public Hospitals in Dominican RepublicLutz, M. A. / Blanco, C. / Baudrit, M. / Cuesta, G. et al. | 2012
- A56
-
PRS29 Health Care Resource Utilization and Costs in Chronic Bronchitis Patients Treated with Copd Medications from a Managed Care Population in the United StatesAbudagga, A. / Sun, S. X. / Tan, H. / Kavati, A. / Solem, C. T. / Botteman, M. F. et al. | 2012
- A57
-
PRS34 The Burden of Asthma in Brazil from the Patient'S PerspectiveVietri, J. / Pomerantz, D. et al. | 2012
- A58
-
PRS39 Palavizumab (Synagis) Use and Outcomes Among Medicaid BeneficiariesDatar, M. / Banahan, B. F. / Null, K. D. / Hardwick, S. P. / Clark, J. P. et al. | 2012
- A59
-
PRS44 Education Plays a Vital Role in the Attitude Toward the Usage of Protective Methods and Resulting Lesser Morbidities among Agate WorkersAggarwal, B. D. et al. | 2012
- A60
-
PRS49 All-Cause 30-Day Readmissions for Matched Inpatients with Copd Receiving Nebulized Short-Acting or Long-Acting Beta AgonistsBollu, V. / Robinson, S. B. / Karafilidis, J. / Rajagopalan, K. / Johnson, B. H. / Walsh, J. S. / Ernst, F. R. / Braman, S. et al. | 2012
- A61
-
PRS55 A New Concept of Patient Reported Outcome on Quality Indicators for Pharmaceutical CareHuttin, C. et al. | 2012
- A62
-
PMD5 Use and Findings of K-Ras in Colorectal Cancer (CRC) Testing in Administrative and Electronic Medical Records (EMR) Data from 2005 Through 2010Seal, B. / Sullivan, S. D. / Ramsey, S. / Kreilick, C. / Foltz-boklage, S. / Haslip, S. / Gilmore, J. / Sarma, S. / Asche, C. / Valluri, S. et al. | 2012
- A63
-
PMD11 Budget Impact of Converting Standard Treatment of Menorrhagia from Rollerball to Thermal Balloon Ablation in Canadian HospitalsGoldstein, L. J. et al. | 2012
- A64
-
PMD16 Forecasting the Prevalence and Economic Burden of Atrial Fibrillation in Selected Countries, 2010 - 2025Rizzo, J. A. / Mallow, P. / Waters, H. / Cirrincione, A. et al. | 2012
- A65
-
PMD22 Comparative Cost Between Vertebroplasty and Kyphoplasty for the Treatment of Vertebral Compression FracturesOng, K. L. / Lau, E. / Kemner, J. E. / Kurtz, S. M. et al. | 2012
- A66
-
PMD27 Cost-Effectiveness of Sacral Nerve Stimulation in Refractory Overactive Bladder: A Canadian PerspectiveSadri, H. / Corcos, J. / Dwyer, N. / Gajewski, J. / Gray, G. / Hassouna, M. / Robert, M. / Tu, L. et al. | 2012
- A67
-
PMD32 Cost-Effectiveness of Drug-Eluting Stents Versus Bare-Metal Stents for Single- and Multi-Vessel Percutaneous Coronary InterventionYan, B. / Lee, V. / Liu, M. / Reid, C. / Yu, C. M. et al. | 2012
- A68
-
PMD38 Cost Minimization Analysis of a Multi-Site Randomized Clinical Trial of Home-Based Versus Laboratory-Based Testing for the Diagnosis and Treatment of Obstructive Sleep Apnea (HomePAP Study)Kim, R. D. / Kapur, V. K. / Redline bruch, J. / Rueschman, M. / Rosen, C. L. / Redline, S. / Ramsey, S. et al. | 2012
- A69
-
PMD43 Preferences of Multiple Sclerosis Patients for Attributes of Self-Injection DevicesSwinburn, P. / Shingler, S. L. / Ali, S. / Perard, R. / Lloyd, A. J. et al. | 2012
- A70
-
PMD49 Do HTA Requirements and Procurement Incentives in Medical Devices Need Re-Aligning?Griffin, A. D. / Chambers, G. / Wilsdon, T. et al. | 2012
- A71
-
PMD54 Urine Drug Monitoring in the Clinic – Who are We Testing, What are We Testing for, and How Often are We Testing?Clancy, Z. A. / Couto, J. / O' / Connell, K. / Moore, N. / Romney, M. et al. | 2012
- A72
-
PMD60 Design of a Bayesian Network As a Decision Model for the Diagnosis of AppendicitisCastillo, M. / Bernal, A. J. / Fajardo, R. et al. | 2012
- A73
-
PSU3 Analysis of Bariatric Outcomes Longitudinal Database (BOLD) to Predict Percent BMI Loss After Bariatric SurgeryBenoit, S. C. / Francis, D. M. / Hunter, T. D. et al. | 2012
- A74
-
PSU8 Disease Burden and Medical Needs in Older Patients with Total Knee Arthroplasties and Muscle Atrophy or WeaknessGreen, J. / Hallett, L. / Zhao, Y. / Birt, J. / Foster, T. et al. | 2012
- A75
-
PSU13 Cost Analysis of Cell Salvage in Pediatric SurgerySamnaliev, M. / Tran, C. / Gasior, I. / Sloan, S. R. / Lightdale, J. / Brustowicz, R. et al. | 2012
- A76
-
PSU19 Comparison of Cost and Operating Room Time of Low Anterior Resection (LAR) Versus Abdominoperineal Resection (APR) Procedures in the United StatesHashemi, L. / Geraci, D. et al. | 2012
- A77
-
PSU24 Cost-Effectiveness of Bariatric Surgery: Laparoscopic Gastric Bypass and BandingMatsuda, T. / Hay, J. et al. | 2012
- A78
-
PSU29 The Importance of Medical Appointments After Roux-en-Y Gastric Bypass in Morbid Obese Patients: Association Between Adherence to Medical Follow-Up Visits and the Bariatric Analysis and Reporting Outcome System (BAROS) Score Based on an Administrative Database (DATASUS) in BrazilAsano, E. / Rasera, I. / Shiraga, E. C. / Cunha, P. G. et al. | 2012
- A79
-
PSU34 Rates and Costs of Hospitalization in Obese Patients with Bariatric SurgeryLao, W. L. / Chia, J. / Globe, D. et al. | 2012
- A81
-
PMH4 Comparison of Risk Adjustment Methods in Predicting Health Care Expenditure among Children with Attention Deficit/Hyperactivity DisorderBali, V. / Johnson, M. L. / Aparasu, R. R. et al. | 2012
- A82
-
PMH9 Description of the Burden Associated with Cognition Deficits in SchizophreniaMillier, A. / Aballea, S. / Toumi, M. / Azorin, J. M. et al. | 2012
- A83
-
PMH14 Predictors of Ambulatory Visit Utilization among Patients with Attention Deficit/Hyperactivity Disorder in the United StatesBali, V. / Franzini, L. et al. | 2012
- A84
-
PMH19 Combination Utilization Patterns and Treatment Predictors in ADHD in a Commercially Insured PopulationBernauer, M. / Farr, A. / Haynes, V. / Montejano, L. B. / Lenhart, G. / Pohl, G. / Kelsey, D. et al. | 2012
- A85
-
PMH24 Differences in Health Care Utilization and Associated Costs Between Patients Prescribed Versus not Prescribed Opioids During an Inpatient or Emergency Department VisitXie, L. / Joshi, A. V. / Harnett, J. / Mardekian, J. / Schaaf, D. / Shah, N. / Baser, O. et al. | 2012
- A86
-
PMH29 Estimates of Schizophrenia-Related Direct Medical Costs Using Attributable and Incremental Cost ApproachesDesai, P. / Lawson, K. et al. | 2012
- A88
-
PMH40 National Estimates and Potential Predictors of Emergency Department (ED) and Inpatient Care Costs for Events Related to Abuse or Misuse of Opioid AnalgesicsChandwani, H. / Strassels, S. / Rascati, K. L. / Lawson, K. / Wilson, J. P. et al. | 2012
- A89
-
PMH45 Utility Scores Associated with the World Health Organisation Drinking Risk-Level Classification in Alcohol DependenceSanglier, T. / Laramé / e, P. / Millier, A. / Guennec, M. / Marteau, F. / Daeppen, J. B. et al. | 2012
- A90
-
PMH50 Psychiatrists' Preferences for Attributes of Antipsychotic Medications to Treat Schizophrenia: A Conjoint AnalysisGelhorn, H. / Gries, K. S. / Cho, C. / Thompson, C. / Fastenau, J. et al. | 2012
- A91
-
PMH55 Racial and Ethnic Differences in ADHD in Young and Adolescent Children: Parental Reports in the Medical Expenditure Panel Survey 2008Yeola, D. C. / Franzini, L. et al. | 2012
- A92
-
PMH60 Health-Related Quality of Life (HRQOL) among Survivors 8 Months and 3 Years After Sichuan 2008 Earthquake in ChinaKe, X. / Chen, Y. / Mock, N. / Shi, L. et al. | 2012
- A93
-
PMH66 Growth in Antidepressant Use in 10 Countries in the Last DecadeMilea, D. / Bent-ennakhil, N. / Jaroslawski, S. / Zard, J. / Toumi, M. et al. | 2012
- A94
-
PMH71 Treatment Utilization Patterns and Expenditures in Depressed Older Adults in the United States: Results from Medical Expenditure Panel SurveyMehta, S. / Aparasu, R. R. et al. | 2012
- A95
-
PMH77 Atypical Antipsychotic Black Box Warning and its Effect on Non-Antipsychotic Psychotropic Drugs in Non-Institutionalized Dementia PatientsSingh, R. R. / Nayak, R. et al. | 2012
- A96
-
PMH82 Do Sales of Pseudoephedrine Predict Methamphetamine-Related Hospitalizations?Freeman, P. R. / Blumenschein, K. / Talbert, J. et al. | 2012
- A97
-
PMH87 Cross-Cultural Adaptation of a Research Version of the Rey Auditory Verbal Learning Test (RAVLT) into (US) SpanishRendu, E. / Caveney, A. / Miner, A. / Nomikos, A. / Acquadro, C. et al. | 2012
- A98
-
PSY4 Prevalence of Autoimmune Diseases and Other Comorbidities in Patients With Psoriasis in the United StatesZhang, F. / Guerin, A. / Gauthier, G. / Day, R. / Khan, Z. et al. | 2012
- A99
-
PSY9 Prevalence of Opioid Abuse and Associated Health Care Resource Utilization and Costs in a Managed Care PopulationRoland, C. L. / Joshi, A. V. / Mardekian, J. / Walden, S. C. / Harnett, J. et al. | 2012
- A100
-
PSY14 Health Care Costs and Opioid Use among Patients With Chronic Low Back Pain Initiating Duloxetine Versus Other TreatmentsHong, J. / Peng, X. / Andrews, J. S. / Novick, D. et al. | 2012
- A101
-
PSY19 Burden of Illness (BOI) of FLT3-Mutated Acute Myeloid Leukemia (AML)Sotak, M. L. / Marin, M. / Coombs, J. / Schiller, G. J. / Teitelbaum, A. et al. | 2012
- A102
-
PSY24 Association of Patient Cost or Reimbursement Challenges With Health Care Resource Utilization, Quality of Life, and Work Productivity Among Patients With Inflammatory Bowel DiseaseVanderpoel, J. / Lofland, J. / Schenkel, B. / Dibonaventura, M. D. / Gross, H. et al. | 2012
- A103
-
PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in MexicoMuciñ / o-Ortega, E. / Leyva-Bravo, V. / Gutié / rrez, C. / Galindo-Suá / rez, R. M. et al. | 2012
- A104
-
PSY35 Economic Evaluation of Lenalidomide in the Management of Previously Treated Multiple Myeloma (PTMM) Patients in GreeceFragoulakis, V. / Kourlaba, G. / Maniadakis, N. et al. | 2012
- A105
-
PSY40 Are Neuropathic Pain (NP) Treatment Benefits Reflected in the Self Assessment of Treatment (SAT) Questionnaire?Wiklund, I. / Holmstrom, S. / Wyrwich, K. / Devine, M. / Stoker, M. et al. | 2012
- A106
-
PSY45 Examining Psoriasis Patient Perspectives of Disease and Treatment: A Novel Multi Discriminate ApproachNaim, A. / Gollins, J. R. / Chen, W. / Walls, D. et al. | 2012
- A107
-
PSY50 Smoking Cessation Medication Utilization Pattern Among Adult Smokers With Different Body Weight Levels – a NAMCS StudyYang, M. / Yu, Y. / Rajan, S. S. / Essien, E. J. / Abughosh, S. et al. | 2012
- A109
-
PSY61 Baseline Characteristics of Over 5,000 Patients Using Nplate® (Romiplostim) in the Nplate® NEXUS (Network of Experts Understanding and Supporting Nplate®) Program, the Nplate® REMS (Risk Evaluation and Mitigation Strategy) Patient RegistrySmith, S. / Batra, M. / Cha, S. / Aycock, J. / Gardner, S. / Eisen, M. et al. | 2012
- A110
-
PSY66 Use of Medicaid Analytic Extract for Evaluation of Drug Use and Health Services Utilization in Patients With HemophiliaBykov, K. / Bohn, R. L. / Ewenstein, B. M. / Avorn, J. L. / Seeger, J. D. et al. | 2012
- A111
-
PCV3 Evaluation of VTE Prophylaxis, Surgical Site Bleeding, and Surgical-Site Infections Following Orthopaedic Arthroplasty: A Nested Case–Control Medical Chart Review StudyFisher, M. / Klaskala, W. / Fields, L. E. / Mills, R. M. / Stephenson, J. J. / Fu, A. C. / Huo, M. et al. | 2012
- A112
-
PCV8 Impct of Comorbidities on Time in Therapeutic Range in Patients with Nonvalvular Atrial FibrillationChoi, J. C. / Damaraju, C. / Mills, R. M. / Wildgoose, P. / Fields, L. / Schein, J. / Nelson, W. W. et al. | 2012
- A113
-
PCV13 Comparison of Cardiac Volume Measurements Using Three-Dimensional and Conventional Echocardiography in DogsPoulsen Nautrup, B. / Penzl, S. / Poulsen Nautrup, C. et al. | 2012
- A114
-
PCV18 Evaluation of Response to Loading Doses of Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention (PCI)Saade, K. / El-hamamsy, M. / Hamdy, M. / Magdy, A. et al. | 2012
- A115
-
PCV23 Prevalence and Incidence of Atrial Fibrillation: An Analysis Based on 8.3 Million PatientsWilke, T. / Groth, A. / Mueller, S. / Verheyen, F. / Linder, R. / Pfannkuche, M. / Maywald, U. / Bauersachs, R. / Breithardt, G. et al. | 2012
- A116
-
PCV29 Missed and Delayed Diagnosis of Stroke in Emergency Department Patients with Headache or DizzinessMoy, E. / Newman-toker, D. E. / Valente, E. / Coffey, R. / Hines, A. L. et al. | 2012
- A117
-
PCV34 Cost and Treatment Duration for Acute Myocardial Infarction in South East AsiaAzmi, S. / Aljunid, S. / Goh, A. / Muhammad nur, A. / Hamzah, S. M. / Ahmed, Z. / Sulong, S. et al. | 2012
- A118
-
PCV39 Determinants of Pharmaceutical Expenditures for Patients with HypertensionCai, B. et al. | 2012
- A119
-
PCV44 Financial Impact of Bleeding Events on Total Knee and Hip Replacements in the Argentinean Health Care SystemCaporale, J. / Aiello, E. / Garay, U. / Lanseros, C. / Waschbusch, M. / Garrido, S. / Alcaraz, A. / Juarez-garcia, A. / Donato, B. M. / Mould, J. F. et al. | 2012
- A120
-
PCV49 Cost-Effectiveness of Cardiac Rehabilitation Program on Patient Medication Adherence and Hospitalization in Medicaid Population with Acute Myocardial InfarctionOu, H. T. / Balkrishnan, R. et al. | 2012
- A121
-
PCV55 Cost-Effectivness of Rosuvastatin Versus Ezetimibe/Simvastatin Fixed Combination in Reaching Cholesterol Goals for Mexican PatientsPolanco, A. C. / Jalon, A. / Rodriguez, I. / Peralta, R. / Ocampo, R. / Lopez-rosas, E. / Cardona, E. et al. | 2012
- A122
-
PCV60 Cost-Utility of Post-Discharge Educational Interventions in Patients with Acute Coronary Syndrome or Chronic Heart FailureCouturier, B. / Carrat, F. / Cohen, A. / Hejblum, G. et al. | 2012
- A123
-
PCV65 Service Utilization, Predictors and Costs among High-Risk Patients with Cardiovascular Disease: Using Real World Data from the Australian Reach RegistryAdemi, Z. / Reid, C. / Bhatt, D. / Steg, P. G. / Liew, D. et al. | 2012
- A126
-
PCV81 Impact of the Awareness of Cardiovascular Disease (CVD) Risk on the Management in Hypertensive Patient in KoreaJeong, M. H. / Kim, D. S. / Chang, H. J. / Park, S. W. / Hong, G. R. / Kim, Y. J. et al. | 2012
- A127
-
PCV86 Comparison of Charlson, Elixhauser and HRQoL-CI Risk Adjustment Measures in Predicting Health-Related Quality of Life in Heart Failure PatientsMehta, H. B. / Aparasu, R. R. / Johnson, M. L. et al. | 2012
- A128
-
PCV91 Development of Methodological Recommendations for Comparative Effectiveness Research on the Treatment of Atrial FibrillationAlavi, R. / Kupferschmidt, B. S. / Spencer, M. R. / Brunner, J. / Desai, P. / Blake, K. / Turkelson, C. et al. | 2012
- A129
-
PCV97 Real World Patient Profile of Patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 Regions of ChinaLi, X. Y. / Crawford, B. / Liao, Y. H. / Wang, D. / Sung, J. C. / Zheng, J. / McDonald, J. et al. | 2012
- A130
-
PCV102 Chronic Heart Failure in the Elderly: Costs and Resource Utilization Following Initial HospitalizatonEldar-lissai, A. / Korves, C. / Wei, R. / Sharma, H. / Chen, K. / Ong, S. H. / Duh, M. S. et al. | 2012
- A131
-
PCV107 Impact of Medication Therapy Management (MTM) on Improving Diabetes Care: A Difference-in-Differences ApproachSoliman, A. M. / Brummel, A. R. / Carlson, A. / Oliveira, D. R. / Dowd, B. et al. | 2012
- A132
-
PCV113 Predictors of Receiving and Adhering to Hypertension Therapeutic and Lifestyle Modification ManagementRobles, L. / Bakhireva, L. / Nawarskas, J. J. et al. | 2012
- A133
-
PCV118 Characteristics of Patients Treated with Thienopyridines Following ACS-PCINordstrom, B. / Simeone, J. C. / Zhao, Z. / Molife, C. / Mccollam, P. L. / Ye, X. / Effron, M. B. et al. | 2012
- A134
-
PCV124 Combining Electronic Health Records and Patient-Reported Information in the UK: Preliminary Results from Wasps (Wales Sail + Pro Study)Cascade, E. / Ford, D. / Nixon, M. / Brooks, C. / Heaven, M. et al. | 2012
- A135
-
PGI6 Visualizing Treatment Patterns of Medicare Patients with Crohn'S Disease Who Initiated Tumor Necrosis Factor TherapyBaser, O. / Wang, L. / Xie, L. / Yuce, H. et al. | 2012
- A136
-
PGI11 Economic Evaluation of the Use of Peg-Interferon Alfa 2A in the Treatment of Patients with Chronic Hepatitis C Public Mexican PerspectiveLechuga, D. / Alva, M. et al. | 2012
- A137
-
PGI16 The Direct Economic Burden of Diverticulitis Recurrence among Managed Care EnrolleesYen, L. / Davis, K. L. / Candrilli, S. D. et al. | 2012
- A138
-
PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated DiseaseMadkour, N. / Bounthavong, M. / Hsu, D. I. et al. | 2012
- A140
-
PND1 A Risk-Benefit Analysis of Natalizumab Across PML Risk Sub-Groups in Patients With Relapsing-Remitting Multiple SclerosisWalker, A. R. / Deniz, B. / Alexopoulos, S. T. / Arnold, R. / Bates, D. et al. | 2012
- A141
-
PND6 Budget Impact Analysis of Antiepileptic Drugs in the Treatment of Lennox-Gastaut SyndromeSkornicki, M. / Clements, K. M. / O'Sullivan, A. K. et al. | 2012
- A142
-
PND11 Cost of Cervical Dystonia in the United StatesBloudek, L. M. / Stacy, M. / Schwartz, M. / Brin, M. / Papapetropoulos, S. et al. | 2012
- A143
-
PND16 Economic Evaluation of Pregabalin and Gabapentin for Neuropathic Pain from the Brazilian Public Health Care System PerspectiveMould, J. F. / Fujii, R. K. / Lazaridis, E. / Manfrin, D. F. et al. | 2012
- A146
-
PND32 Potential Humanistic Benefits of Pegylation in the Treatment of Multiple Sclerosis: A Systematic Review of the LiteratureBecker, R. V. et al. | 2012
- A147
-
PND37 Predictors of Poor Health-Related Quality of Life in Patients With Epilepsy: Insight From the Patientslikeme® Epilepsy Communityde la Loge, C. / Dimova, S. / Mueller, K. / Durgin, T. / Massagli, M. P. / Wicks, P. et al. | 2012
- A148
-
PND42 Burden of Disease in Caregivers of Alzheimer's Disease in Brazil: Results From 2011 National Health and Wellness Survey (NHWS)Mould, J. F. / Fujii, R. K. / Paganini, P. / Manfrin, D. F. et al. | 2012
- A149
-
PND47 Rescue Medication Use in the Acute Treatment of Migraine During Map0004 Pivotal TrialKori, S. / Kellerman, D. / Chen, S. / Lu, B. et al. | 2012
- A150
-
PND52 Determining the Existence of Racial and Ethnic Disparities in Alzheimer's Disease Pharmacotherapy Exposure: An Analysis Across Four State Medicaid PopulationsGilligan, A. / Malone, D. / Warholak, T. L. / Armstrong, E. P. et al. | 2012
- A151
-
PND57 Value-Based Insurance Design in Multiple Sclerosis (MS): Emerging Models and Implications for Development of Real-World DataSnyder, T. / Dobrovolny, D. / Lui, J. / Paas, M. et al. | 2012
- A153
-
PUK8 Nocturia and the Risk of Falls, Fractures, and Sleep Disturbance: a Systematic Review and Meta-AnalysisTsai, K. / Globe, D. / Malone, D. C. et al. | 2012
- A154
-
PUK14 Cost Analysis of Anemia Management in Hemodialysis Patients in 2009: a French Multicenter Retrospective StudyTilleul, P. / Rottembourg, J. / Lafuma, A. / Emery, C. / Zakin, L. / Braunhofer, P. / Mahi, L. / Deray, G. / Wernli, J. et al. | 2012
- A155
-
PUK19 Incremental Cost-Effectiveness of Pharmacist-Managed Erythropoiesis-Stimulating Agents Clinics for Non-Dialysis Chronic Kidney Disease PatientsAspinall, S. L. / Smith, K. J. / Good, C. B. / Zhao, X. / Stone, R. A. / Tonnu-mihara, I. Q. / Cunningham, F. E. et al. | 2012
- A156
-
PUK24 Examining the Role of Caregiver Towards Blood Transfusion Decisions among Individuals with Chronic Kidney DiseaseNaim, A. / Walls, D. / Gollins, J. R. / Reynolds, C. et al. | 2012
- A157
-
PUK29 Erythropoietin-Stimulating Agent (ESA) Dose Recovery Following Hospitalization of End Stage Renal Disease (ESRD) PatientsWang, X. / Bond, T. C. / Rubin, J. L. / Yang, A. et al. | 2012
- A158
-
PUK35 EQ-5D (UK and Thai Preference Weights), SF-6D, and VAS Scores in Dialysis Thai PatientsThaweethamcharoen, T. / Vasuvattakul, S. / Noparatayaporn, P. et al. | 2012
- A159
-
PRM4 Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing: Opportunities and Challenges Associated with an Integrated Personalized Medicine ApproachPayne, K. A. / Frueh, F. W. / Sohal, J. et al. | 2012
- A160
-
PRM10 The Behavioral Economics of the Minimally Important DifferenceSuh, J. K. / Doctor, J. et al. | 2012
- A162
-
PRM22 Comparison of Methods for the Evaluation of Ustekinumab Dosing and Costs in Pharmacy Claims DatabasesCarter, C. / Haas, S. / Gunnarsson, C. / Martin, S. et al. | 2012
- A164
-
PRM34 Estimating Markov Chain Transition Matrices in Limited Data Samples: A Monte Carlo ExperimentTsang, K. P. / Wang, B. C. / Garrison, L. et al. | 2012
- A165
-
PRM39 Examination of Starting Point Bias with the Bidding Game: Evidence from a Systematic Review of the Literature on Willingness-to-Pay AnalysesIskedjian, M. / Navarro, V. / Berbari, J. / Lelorier, J. et al. | 2012
- A166
-
PRM44 Pseudo-Randomization in Retrospective Analysis Using the Generalized Multinomial Logit for Propensity Score GenerationWilson, S. M. / Mayne, T. et al. | 2012
- A168
-
PRM57 Cost-Effectiveness Analysis in Personalized Medicine: General Hypotheses and Corresponding Decision Tree Structures for Screening, Diagnostic, Predictive, Prognostic, Surveillance, and Monitoring TestsMladsi, D. M. / Herring, W. L. / Earnshaw, S. R. et al. | 2012
- A169
-
PRM62 Visual Assessment of Fit of Equations to Predict Time-to-Event OutcomesIshak, K. et al. | 2012
- A170
-
PDB3 Risk of Complications in Type II Diabetic Patients With Renal Impairment: an Analysis of the Ramq DatabaseLachaine, J. / Beauchemin, C. / Flavin, J. et al. | 2012
- A171
-
PDB8 the Effect of Dapagliflozin on Hedis Performance Measures of Hba1C in Patients with Type 2 Diabetes MellitusBell, K. / Hardy, E. / De Bruin, T. / Wei, L. / Martin, P. / Ptaszynska, A. et al. | 2012
- A172
-
PDB13 Short Stature in Turner Syndrome: Basal Characteristics and Follow-Up of a Colombian CohortNuñ / ez, S. M. / Arango, A. / Balthazar, V. / Chahin, S. / Duran, P. / Jaimes, G. C. / Manrique, L. A. / Matallana, A. M. / Mejia, L. et al. | 2012
- A174
-
PDB24 Prevalence and Incidence of Type 2 Diabetes Mellitus: An Analysis Based on 5.4 Million PatientsWilke, T. / Groth, A. / Mueller, S. / Ahrendt, P. / Schwartz, D. / Linder, R. / Ahrens, S. / Verheyen, F. et al. | 2012
- A175
-
PDB30 A Comparison of the Costs for Treating Central Precocious Puberty During the First Year With Leuprolide Acetate Injectible and Histrelin Acetate ImplantBanahan, B. F. / Mayo, K. / Summers, K. H. et al. | 2012
- A177
-
PDB41 Impact of Sustained Hemoglobin A1C Control on Health Care Costs Among Patients With Diabetes in HawaiiJuarez, D. / Goo, R. / Tokumaru, S. / Sentell, T. / Davis, J. / Mau, M. et al. | 2012
- A178
-
PDB46 Direct Medical Costs of Treating Diabetes Related Complications in MexicoVega-Herná / ndez, G. / Jugrin, A. / Radford, M. / Bloomfield, E. / Todorova, L. / Hansen, B. et al. | 2012
- A179
-
PDB51 Medication Adherence and Medical Costs Associated With Exenatide Bid Versus Liraglutide: A Retrospective Database AnalysisPelletier, E. M. / Pawaskar, M. / Chapman, R. et al. | 2012
- A180
-
PDB56 Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients With Type 2 Diabetes Failing Metformin MonotherapyLanger, J. / Hunt, B. / Valentine, W. J. et al. | 2012
- A181
-
PDB62 Cost-Effectiveness Modelling of Type-1 DiabetesThokala, P. / Kruger, J. / Brennan, A. et al. | 2012
- A182
-
PDB67 Impact of Adherence to Oral Diabetes Medication on Short-Term Disability Costs in an Employer PopulationWright, D. / Hagen, S. / Finch, R. / Edington, D. et al. | 2012
- A184
-
PDB78 Variation in Attachment Style and Health Outcomes of Diabetes PatientsSansgiry, S. / Naik, A. D. / Brown, A. C. / Latini, D. M. et al. | 2012
- A185
-
PDB83 Diabetes Medication Usage Patterns in Geographies With High Hispanic Populations in the United StatesDockery, J. D. / Smith, D. E. / Navaneetha Krishnan, S. et al. | 2012
- A186
-
PDB88 Impact of Telephone and Mail Intervention on Diabetes Appointment Adherence Rates and Clinical OutcomesJiang, S. / Bamgbade, B. / Barner, J. C. / Klein-Bradham, K. / Janiga, X. / Brown, B. et al. | 2012
- A187
-
PDB93 Impacts of Drug Reimbursement Rate Reductions on Use of Oral Antidiabetic Medications in Taiwan: An Interrupted Time Series StudyHsu, C. S. / Lu, C. Y. / Wagner, A. / Chan, K. W. / Lai, M. S. / Ross-degnan, D. et al. | 2012
- A188
-
PDB98 Treatment Patterns and Treatment Restrictions of Patients With Type II Diabetes Receving Care From Home Health Care Agencies, Skilled Nursing Facilities, and Veterans Affairs Settings in the United StatesGanz, M. L. / Strand, L. / Kongsø / J. H. et al. | 2012
- A189
-
PDB103 Predictors of Hospital Readmissions in Patients With Diabetes: Results From the 1999-2009 Medical Expenditure Panel SurveyDesai, V. C. / Kelton, C. M. / Tundia, N. L. / Heaton, P. C. et al. | 2012
- A190
-
PDB109 Comparative Performance of Comorbidity Measures to Risk-Adjust Health Related Quality of Life in Diabetes PatientsPatel, H. K. / Johnson, M. L. / Aparasu, R. R. et al. | 2012
- A191
-
PIH3 Use of Mixed Treatment Comparison Methods in Estimating Efficacy of Treatments for Heavy Menstrual BleedingHoaglin, D. / Filonenko, A. / Wasiak, R. et al. | 2012
- A192
-
PIH8 Medication Use and Hospital Admission Rates among Preterm Born Infants Compared to Full Term Born InfantsHouweling, L. M. / Bezemer, I. D. / Penning, F. J. / Van Lingen, R. A. / Meijer, W. M. / Herings, R. M. et al. | 2012
- A194
-
PIH19 Impact of Insurance Coverage for in Vitro Fertilization on the Cost Per Live Birth in the USAtzinger, C. B. / Schauer, D. P. / Eckman, M. H. et al. | 2012
- A195
-
PIH24 Modeling the Health and Medical Care Spending of the Future Elderly: An Update Using the Future Elderly ModelLakdawalla, D. / Goldman, D. / Philipson, T. et al. | 2012
- A196
-
PIH29 Adherence among Initiators and Switchers on Generic, Preferred and Non-Preferred Brand TherapiesAverbukh, A. N. / Matlin, O. S. / Chang, A. / Kyrychenko, P. / Fredell, J. W. et al. | 2012
- A197
-
PIH34 Impact of Medicare Part D Coverage Gap on Beneficiaries' Adherence to Prescription MedicationsDesai, U. / Carroll, N. V. et al. | 2012
- A198
-
PIH39 Eliciting Preferences to the EQ-5D-5L Health States: Discrete Choice Experiment or Multiprofile Case of Best-Worst ScalingXie, F. / Pullenayegum, E. / Gaebel, K. / Oppe, M. / Krabbe, P. F. et al. | 2012
- A199
-
PIH45 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in ShenyangZhang, F. / Du, J. / Li, S. C. et al. | 2012
- A200
-
PIH50 Factor Structure of the Nhanes Physical Function Limitation Questionnaire and its Relationahip with Muscle Measurements in US Elderly Aged 60-80 YearsChen, L. / Naegeli, A. / Watson, P. / Nelson, D. R. / Meldahl, M. L. / Peltz, G. / Zhao, Y. et al. | 2012
- A202
-
PIH61 Burden of Disease in Patients with Menopause in Brazil: Results from 2011 National Health and Wellness Survey (NHWS)Mould, J. F. / Fujii, R. K. / Boulos, F. C. / Manfrin, D. F. et al. | 2012
- A203
-
PIH66 Do we Need a Gender-Specific Health Related Quality of Life –Comorbidity Index?Gupta, P. / Aparasu, R. R. / Johnson, M. et al. | 2012
- A205
-
PIH78 Effect of Hospital Wastes on Drinking Water Quality of KPK Hospitals PakistanBibi Saima Zeb, B. S. / Saira Azhar, D. S. / Qaisar Mahmood, Q. M. et al. | 2012
- A206
-
PIH83 Health Technology Assessment in Child HealthUngar, W. et al. | 2012
- A207
-
PCN3 Relationship Between Comorbidities and Late-Stage Prostate Cancer Diagnosis among Men in FloridaXiao, H. / Tan, F. / Gwede, C. / Goovaerts, P. / Huang, Y. / Ali, A. / Adunlin, G. et al. | 2012
- A208
-
PCN8 Primary Androgen Deprivation Therapy Versus Radical Prostatectomy in Seer-Medicare Dataset: A Comparative Effectiveness Analysis of Retrospective CohortsLiu, J. / Shi, L. / Sartor, O. / Culbertson, R. et al. | 2012
- A209
-
PCN13 Cost-Effectiveness Analysis of Nilotinib Versus Dasatinib in Patients With Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia (CML)Niu, X. / Hay, J. et al. | 2012
- A211
-
PCN25 Effect of Treatments for Late-Stage Prostate Cancer on SurvivalAli, A. A. / Xiao, H. / Adunlin, G. B. et al. | 2012
- A212
-
PCN31 Economic Evaluation of Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) in the Brazilian Public Health Care System (SUS)Paladini, L. / Pepe, C. / Clark, O. A. / Tencer, T. / Khan, Z. et al. | 2012
- A213
-
PCN36 Epoetin Alfa and Darbepoetin Alfa Dosing Patterns and Costs in Chemotherapy-Induced Anemia InpatientsLafeuille, M. H. / Forlenza, J. B. / Khan, A. / Laliberté / Lefebvre, P. et al. | 2012
- A214
-
PCN41 Economic Burden Associated With Adverse Events in Patients With Metastatic Renal Cell CarcinomaBorker, R. D. / Knapton, L. M. et al. | 2012
- A217
-
PCN57 Cost Effectiveness of Nilotinib Versus Imatinib as First Line Treatment for Newly Diagnosed Hong Kong (HK) Patients With Chronic Phase, Philadelphia Chromosome-Positive (PH+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Hong KongTse, V. / Liu, H. / Botteman, M. / Mcghee, S. / Lee, V. W. / Lee, K. K. et al. | 2012
- A219
-
PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian PerspectivesXue, M. / Fishman, P. / Botteman, M. et al. | 2012
- A220
-
PCN72 Cost Effectiveness Analysis of New Treatments for Metastatic Castration-Resistant Prostate Cancer: Does Severity Matter?Wilson, L. S. / Zhong, L. / Pon, V. / Srinivas, S. / Frear, M. / Nguyen, N. / Gong, C. / Kwon, S. / Malmstrom, R. / Loucks, A. et al. | 2012
- A221
-
PCN78 The Cost-Effectiveness of Temozolomide in the Adjuvant Treatment of Newly Diagnosed Glioblastoma in the United StatesMessali, A. / Hay, J. / Villacorta, R. et al. | 2012
- A222
-
PCN84 Economic Evaluation of the Use of Capecitabine as First-Line Treatment of Metastatic Colorectal Cancer in MexicoLechuga, D. / Alva, M. / Leyva, V. / Salinas, G. E. et al. | 2012
- A223
-
PCN89 Economic Evaluation of Erlotinib as Treatment of or Metastasic Cancer of Non-Small Cell Lung Cancer (NSCLC) Prior Chemotherapy in MexicoLechuga, D. / Alva, M. / Sanchez-Kobashi, R. / Gay, J. G. et al. | 2012
- A224
-
PCN95 Using a Condition-Specific Measure of Patient-Reported Outcomes to Derive Utilities in MyelofibrosisRoskell, N. S. / Mendelson, E. T. / Whalley, D. / Knight, C. et al. | 2012
- A226
-
PCN106 Development of a Guidance for Including Patient-Reported Outcomes (PROs) in Late-Phase Adult Clinical Trials of Oncology Drugs for Comparative Effectiveness Research (CER)Basch, E. M. / Abernethy, A. P. / Mullins, C. D. / Spencer, M. R. et al. | 2012
- A227
-
PCN111 Evaluating Meaningful Change on the Lung Cancer Symptom Scale in Small Cell Lung Cancer: Results From a Phase III Clinical TrialO' / Brien, M. / Hudgens, S. / King, J. / McNally, R. / Khan, Z. et al. | 2012
- A228
-
PCN116 Using the Modified RAND/UCLA Delphi Process to Produce Treatment Consensus in Unresectable Midgut Gastrointestinal Neuroendocrine TumorsStrosberg, J. R. / Fisher, G. / Benson, A. B. / Malin, J. L. / Anthony, L. / Arslan, B. / Gibbs, J. F. / Greeno, E. / Iyer, R. / Kim, M. K. et al. | 2012
- A229
-
PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast CancerLandsman-Blumberg, P. / Namjoshi, M. / Thomson, E. / Johnson, W. et al. | 2012
- A230
-
PCN126 Radiation After Breast-Conserving Surgery: Compliance of Clinical Guideline Among Young Women With Employment-Based Insurance in the United StatesPan, I. W. / Smith, B. D. / Shih, Y. C. et al. | 2012
- A231
-
PCN131 Patients' Out-of-Pocket (OOP) Costs for Granulocyte Colony-Stimulating Factors (G-CSF)Tomic, K. S. / Long, S. / Li, X. / Yu, J. / Fu, A. C. / Barron, R. et al. | 2012
- A232
-
PCN137 Surgery, Radiation, and Systemic Therapies in Patients With Metastatic MelanomaWang, S. / Zhao, Z. / Barber, B. / Wagner, V. et al. | 2012
- A233
-
PCN142 Association of Health-Related Quality of Life Among Patients With Multiple Myeloma With Insurance CoveragePashos, C. L. / Durie, B. G. / Rifkin, R. M. / Abonour, R. / Fonseca, R. / Gasparetto, C. / Mehta, J. / Narang, M. / Shah, J. J. / Terebelo, H. R. et al. | 2012
- A234
-
PCN147 Evaluating Contemporary Practice in Cml via a Retrospective Research Registry of Patients Across a Comprehensive Cancer Center DatabaseStenehjem, D. / Albright, F. / Kuo, K. L. / Raimundo, K. / Brixner, D. et al. | 2012
- A235
-
PCN154 Challenges Posed by Patient Crossover for Cost-Effectiveness Analysis of Oncology Products: A Case Study in Metastatic Pancreatic CancerGrima, D. T. / Brown, S. T. / Attard, C. L. / Duong, M. T. et al. | 2012
- A236
-
PIN1 Outcomes Associated With Severe Comorbidities in Hospitalized Cases of HIV/AIDSVilla, L. / Skrepnek, G. et al. | 2012
- A237
-
PIN6 Evaluation of the Clinical and Economic Burden of the Human Immunodeficiency Virus in Veteran Patients in the United StatesBaser, O. / Wang, L. et al. | 2012
- A238
-
PIN11 Costs of Adverse Events Among Patients With Human Immunodeficiency Virus Treated With Non-Nucleoside Reverse Transcriptase InhibitorsSimpson, K. N. / Chen, S. Y. / Wu, A. / Boulanger, L. / Khachatryan, A. / Chambers, R. / Tawadrous, M. / Pashos, C. L. / Haider, S. et al. | 2012
- A239
-
PIN17 Cost of Treatment Failure Among Adult Outpatients With Moderate or Complicated Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Skin Infections: A Starnet StudyLabreche, M. J. / Lee, G. / Mortensen, E. M. / Dallas, S. D. / Du, L. C. / Nyren, N. R. / Pena, J. / Rocha, G. / Esparza, S. / Finnie, M. et al. | 2012
- A240
-
PIN22 Economic Burden of Hospitalization With Antibiotic Treatment for Absssi in the United States: An Analysis Ofthe Premier Hospital DatabaseLaPensee, K. T. / Fan, W. / Wang, Y. et al. | 2012
- A241
-
PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C PatientsCure, S. / Curtis, S. / Bianic, F. / Gavart, S. / Dearden, L. / Fleischmann, J. / Ouwens, M. / Lee, S. et al. | 2012
- A242
-
PIN32 Cost-Effectiveness Analysis of Tigecicline in the Treatment of Complicated Intra-Abdominal Infection in MexicoTellez-Giró / n, G. / Soto-Molina, H. / Rizzoli-Có / rdova, A. / Dí / az-Ponce, H. / Galindo-Suá / rez, R. M. et al. | 2012
- A243
-
PIN37 Cost-Effectiveness of Treatment Initiation With Ritonavir-Boosted Atazanavir (ATV/R) and Lopinavir (LPV/R) in Treatment-NaÏve HIV Patients at Different CD4 Levels at BaselineVerheggen, B. / Aldir, I. / Tan, C. / Carrasco, J. / Antunes, A. / Lescrauwaet, B. et al. | 2012
- A244
-
PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients: A Post-Hoc Analysis of Il-28B SubgroupCurtis, S. / Cure, S. / Bianic, F. / Gavart, S. / Dearden, L. / Fleischmann, J. / Ouwens, M. / Lee, S. et al. | 2012
- A245
-
PIN47 The Humanistic and Economic Burden of Hepatitis C Across the United States, Europe, and AsiaDiBonaventura, M. D. / Yuan, Y. / Lescrauwaet, B. / L'Italien, G. / Liu, G. G. / Kamae, I. / Mauskopf, J. A. et al. | 2012
- A246
-
PIN54 Access to Medication for Uninsured Individuals Living with HIV/AIDS in the United StatesWolfe, R. / Weinlein, M. / Rizzo, M. et al. | 2012
- A247
-
PIN59 Assessing the Awareness About Human Papillomavirus (HPV) and Attitude Towards the Hpv Vaccine in a Cohort of Male College StudentsMedhekar, R. A. / Hatfield, M. D. / Sansgiry, S. S. et al. | 2012
- A248
-
PIN64 Burden of Pneumococcal Infection in Adults in ColombiaRosselli, D. / Rueda, J. D. et al. | 2012
- A249
-
PSS1 Relieving the Pruritus of Atopic Dermatitis: A Meta-AnalysisSher, L. / Chang, J. / Patel, I. / Balkrishnan, R. / Fleischer, A. B. et al. | 2012
- A251
-
PSS12 Economic Analysis of Etanercept as Continuous or Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in VenezuelaFernandes, R. A. / Takemoto, M. L. / Amaral, L. M. / Cruz, R. B. / Mould, J. F. / Rodriguez, J. C. et al. | 2012
- A253
-
PSS22 A Comprehensive Health Impact Assessment and Determinants of Quality of Life, Health and Psychological Status in Acne PatientsPagliarello, C. / di Pietro, C. / Tabolli, S. et al. | 2012
- A254
-
PSS27 Relationship Between Weight and Dose in Psoriasis Patients Treated with UstekinumabSchmeichel-Mueller, C. / Goren, A. / DiBonaventura, M. D. / Martin, S. et al. | 2012
- A255
-
PSS32 Pharmacoeconomic Evaluation of Bacterial Eye Inflammation Treatment in RussiaSerpik, V. G. / Yagudina, R. et al. | 2012
- A257
-
ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations| 2012
- A266
-
ISPOR 17th Annual International Meeting Research Abstracts Author Index| 2012
- i
-
Table of Contents| 2012
- I
-
Guide for Authors| 2012
-
CV3 Comparative Effectiveness of Statins in a Large Managed Care Organization: Cardiovascular Event Rate and Total Health Care CostWang, J. J. / White, T. J. / Fisher, V. S. / Devries, A. / Mcneeley, B. / Abarca, J. et al. | 2012
-
DR4 Clarity, Consistency and Transparency in Decision-Making: Testing a Novel P&T Framework for Assessing EvidenceGraff, J. / Dean, B. / Ko, K. / Localio, A. R. / Dubois, R. W. et al. | 2012
-
HC3 Assessing the Value of Biopharmaceuticals: Cost-Effective Innovations or Inefficient Use of Resources?Wilson, A. / Neumann, P. J. et al. | 2012
-
PR4 Breast Cancer Mortality Rates by Geographic Region, Years of Potential Life Lost, and Value of Productivity Losses among Women Aged 20-49 Years in the United States, 1970–2008Ekwueme, D. U. / Guy, G. P. / Rim, S. H. / Hall, I. J. / Thomas, C. C. / Fairley, T. L. / Rodriguez, J. / White, A. et al. | 2012
-
QU3 Psychometrics of the Actinic Keratosis Risk Questionnaire: A Risk Assessment InstrumentBalkrishnan, R. / Kulkarni, A. S. / Gatwood, J. / Anderson, R. T. / Narahari, S. / Landis, E. / Feldman, S. R. et al. | 2012
-
PHP4 Health Literacy and its Impact on National Health Care UtilizationAgbor Bawa, W. / Rasu, R. et al. | 2012
-
PHP9 Consensus-Based Policy Solutions for Medicines Adherence for Europe: Development and EvaluationClyne, W. / White, S. / McLachlan, S. et al. | 2012
-
PHP37 Are Hospital Inpatient Costs Lower for Medicare Advantage Enrollees Than Medicare Fee-for-Service Beneficiaries?Karaca, Z. / Wong, H. et al. | 2012
-
PHP41 One-Year Assessment of Joint Procurement of Pharmaceuticals in the Public Health Sector in JordanAlabbadi, I. / Qawwas, A. / Jaafreh, M. / Abosamen, T. / Saket, M. et al. | 2012
-
PHP44 International Comparison of Pharmaceutical Expenditure in Middle Income Countries: Methodological QuestionsKalo, Z. / Inotai, A. / Meré / sz, G. et al. | 2012
-
PHP57 An Analysis of Intravenous Medication Errors Using Incident Reports at a Teaching Hospital in JapanTsuda, Y. / Hirose, M. / Egami, K. / Ohama, K. / Honda, J. / Shima, H. et al. | 2012
-
PHP63 Economic, Clinical and Humanistic Outcomes of a Collaborative Pharmacist- Physician Medication Therapy Management Service for Polypharmacy ElderlyLin, H. W. / Lin, C. H. / Chang, C. K. / Yu, I. W. / Lin, C. C. / Li, T. C. / Li, C. I. / Hung, J. S. et al. | 2012
-
PHP69 Trends of Emergency Room Visits Versus Hospitalizations Due to Unintentional Poisonings in Kansas City, MissouriLiu, Y. / Cai, J. / Hong, L. / Hoff, G. L. / Okah, F. A. et al. | 2012
-
PHP82 Comparative Analysis of Diseases Prevalence Rates in General Ukrainian Population and Subpopulations of War Veterans and Chernobyl VictimsBocharova, V. / Zalis' / ka, O. / Tolubaiev, V. / Majnych, J. et al. | 2012
-
PHP98 The Future of Alternative Pricing/Risk-Sharing Agreements in the United StatesGoldenberg, D. / Bachman, E. M. et al. | 2012
-
PHP99 How to Deal With Decision Uncertainty? The Italian Experience With Managed Entry AgreementsSiviero, P. D. / Sammarco, A. / Tafuri, G. / Pani, L. et al. | 2012
-
PMS5 Data Visualization of Treatment Patterns of Medicare Psoriatic Arthritis Patients Who Initiate Tumor Necrosis Factor TherapyBaser, O. / Wang, L. / Xie, L. / Yuce, H. et al. | 2012
-
PGI9 Impact of Switching Patients from Twice Daily Proton Pump Inhibitors to Once Daily DexlansoprazoleParthan, A. / Mody, R. R. / Deflin, M. M. / Akhras, K. S. et al. | 2012
-
PGI15 The Economic Burden of Unmet Treatment Needs in Medicaid Patients with Chronic ConstipationCarson, R. T. / Guerin, A. / Lewis, B. / Yin, D. / Kaminsky, M. / Ramakrishnan, K. / Wu, E. Q. et al. | 2012
-
PGI17 Societal Burden in Patients with Liver Transplantation: The Come Study ResultsFusco, F. / Scalone, L. / Fagiuoli, S. / Ciampichini, R. / Gaeta, L. / Del prete, A. / Gardini, I. / Mantovani, L. G. et al. | 2012
-
PGI22 Cost-Effectiveness Analysis of Proton Pump Inhibitors for Treatment of Severe Gastroesophageal Reflux Disease in MexicoPozo Urquizo, L. / Latapi, E. / Soto Molina, H. / Polanco, A. C. et al. | 2012
-
PGI26 Resource Utilization and Costs Associated with Diverticulitis Inpatient Admissions: An Analysis of the Economic Burden of DiverticulitisSpiegel, B. / Poysophon, P. / Snyder, B. / Agarwal, N. / Yen, L. / Hodgkins, P. / Cohen, E. / Vu, M. / Kurzbard, N. / Atia, M. et al. | 2012
-
PND25 The Role of Structural Sensitivity Analysis in the Modelling of Cost-Effectiveness (Cost-Utility) in Parkinson's Disease in the United States and United KingdomRatcliffe, A. E. et al. | 2012
-
PND40 Assessment of Dementia Risk Among Caregivers of Alzheimer's Care RecipientsMajethia, U. / Nayak, R. et al. | 2012
-
PND41 Parkinson's Disease Questionnaire (PDQ-39) As a Primary Endpoint in a Trial Comparing Deep Brain Stimulation With Best Medical Therapy Versus Best Medical Therapy Alone for Advanced Parkinson's Disease (PD SURG TRIAL): A Randomised, Open-Label TrialJenkinson, C. / Williams, A. / Ives, N. / Rick, C. / Daniels, J. / Patel, S. / Wheatley, K. / Churchman, D. et al. | 2012
-
PND48 Real World Treatment Profile of Patients With Tuberous Sclerosis ComplexSun, P. / Liu, Z. / Kohrman, M. et al. | 2012
-
PUK5 a Systematic Review and Meta-Analysis of Solifenacin Succinate Versus Trospium Chloride for Overactive BladderOdeyemi, A. / Hart, W. M. / Nazir, J. et al. | 2012
-
PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with HyperphosphatemiaMutell, R. / Rubin, J. L. / Bond, T. C. / Mayne, T. et al. | 2012
-
PRM18 Review of Administration's Cost Assumption of Rotavirus and Pneumococcal Vaccines Cost-Effectiveness AnalysesDe la Hoz-Restrepo, F. / Castañ / eda-Orjuela, C. A. / Alvis, N. / Paternina, A. et al. | 2012
-
PRM20 Comparing the Use of Secondary Data Sources in Two Types of Journals During 2010Akridge, J. / Zreikat, H. H. / Harpe, S. E. et al. | 2012
-
PRM65 Prevalence-Based Versus Incidence-Based Economic Evaluations for the Assessment of New Health Care InterventionsMauskopf, J. A. et al. | 2012
-
PDB19 A Comparison of Standards of Diabetes Care Across Different Racial/Ethnic Groups in the United States Non-Institutionalized Adult Population: A Study Using the 2009-2010 Nhanes CohortPerez, A. / Quansah, K. A. / Sanchez, J. et al. | 2012
-
PDB29 Budget Impact Analysis of Norditropin Versus Three Leading Market Growth Hormone TherapiesSolem, C. T. / Smith, C. / Wiegand, P. / Botteman, M. / Germak, J. / Wisniewski, T. et al. | 2012
-
PDB42 Health Care Resources Utilization and Cost for Hypoglycemia and Metabolic Acidosis in Type Ii Diabetes: an Analysis of the Ramq DatabaseLachaine, J. / Beauchemin, C. / Flavin, J. et al. | 2012
-
PDB45 Direct Medical Costs of Diabetes-Related Complications in Saudi ArabiaHnoosh, A. / Vega-Herná / ndez, G. / Jugrin, A. / Todorova, L. et al. | 2012
-
PDB100 Health Care Utilization and Cost Patterns Among Diabetes Patients Prior to Initiation With Saxagliptin and Other (Non-Insulin) Antidiabetic Medications in a US Health PlanWilliams, S. / Thayer, S. / Fan, Y. / Parasuraman, S. et al. | 2012
-
PDB104 Economic and Clinical Analysis of a Medication Management Program Targeting Patients With Uncontrolled Diabetes: A Two-Year AnalysisSuh, K. / Prasla, K. / Gorsh, B. / Tabor, T. / Godley, P. J. / Chaddick, J. et al. | 2012
-
PDB107 Patient Characteristics and Outcomes Among Individuals With Type 2 Diabetes: A Comparison Based Upon AdherenceEby, E. / Lage, M. / Mitchell, B. et al. | 2012
-
PIH5 Systematic Review Comparing the Efficacy of the 5-Alpha Reductase Inhibitors (5-Aris) Dutasteride and Finasteride in the Treatment of Benign Prostatic Hyperplasia (BPH)Conte, T. / Truzzi, J. C. / Tannus, G. / Fonseca, M. et al. | 2012
-
PIH7 Risk of All-Cause Hospitalization in Dual Eligible Beneficiaries Using Antipsychotic AgentsAparasu, R. R. / Chatterjee, S. et al. | 2012
-
PIH15 Application of Probabilistic Linkage: Compare Health Care Costs among Menopausal Women with Different Symptoms by Linking Women's Registry and Claims DatabaseBaser, O. / Xie, L. / Du, J. / Smith, Y. et al. | 2012
-
PIH38 The Relative Influence of Perceived Need for Medications Versus Perceived Medication Concerns in Determining Medication Adherence: Narrative Systematic Review and Meta-AnalysisZhang, N. J. / McHorney, C. et al. | 2012
-
PIH57 Application of the Bother Concept Across CulturesGawlicki, M. C. / Mckown, S. / Talbert, M. / Brandt, B. A. et al. | 2012
-
PIH62 Over-the-Counter Medication Use and its Impact on Quality of Life of the ElderlyMhatre, S. / Sansgiry, S. et al. | 2012
-
PIH65 Psychometric Validation of the Tummy Tuck QuestionnaireAbrams, S. / Hudgens, S. / Banderas, B. / Krishnan, S. / Ito, D. / Li-McLeod, J. et al. | 2012
-
PIH69 Willingness to Pay for Vasomotor Symptoms Treatment in KoreaSon, M. J. / Park, H. J. / Ko, S. K. et al. | 2012
-
PIH70 Is Primary Care Accessible for the Poor in Mongolia?Chimeddamba, O. et al. | 2012
-
PCN26 A Budget Impact Analysis of Vinorelbine Introduction on Croatian Positive Drugs List in Breast Cancer TreatmentVitezic, D. / Hadzic-Kostrencic, C. / Petkovic, M. / Mrsic Pelcic, J. et al. | 2012
-
PCN33 Indirect Analysis of the Efficacy and Safety of Pemetrexed/Cisplatin Compared With Bevacizumab/Gemcitabine/Cisplatin as First-Line Treatment for Advanced, Non-Squamous Non-Small Cell Lung Cancer and Associated Treatment Costs in the Private Mexican Health Care SystemRamirez Gamez, J. / Cruz Cadena, A. / Davey, P. / Rajan, N. / Barraclough, H. / Orlando, M. et al. | 2012
-
PCN48 Costs Associated to Treatment of Metastatic HER2 Positive Breast Cancer After Progression to Trastuzumab Under the Perspective of the Brazilian Private Health Care SystemClark, O. A. / Teich, V. et al. | 2012
-
PCN63 Addition of Bivalent or Quadrivalent HPV Vaccines to Cervical Cancer Screening, in Colombia. A Cost- Effectiveness AnalysisAponte, J. / Eslava-Schmalbach, J. / Gamboa, O. / Fajardo, L. et al. | 2012
-
PCN66 Economic Evaluation of Abiraterone Acetate as Treatment for Metastatic Castration Resistant Prostate Cancer After Failure of Docetaxel in SwedenPersson, U. / Nilsson, S. / Hjortsberg, C. / Prû / tz, C. et al. | 2012
-
PCN98 The Development of an Internationally-Valid Cancer-Specific Multi-Attribute Utility Instrument (MAUI) From the Eortc Core Health-Related Quality of Life (HRQOL) Questionnaire, QLQ-C30King, M. / Costa, D. S. / Aaronson, N. K. / Brazier, J. / Cella, D. F. / Fayers, P. / Pallant, J. F. / Peacock, S. / Pickard, A. S. / Rowen, D. et al. | 2012
-
PCN105 Patient-Reported Outcomes (PROs) and Tolerability of Therapeutic Agents in Patients With Metastatic Prostate Cancer (MPC): A Systematic Literature ReviewSeal, B. / Puto, K. / Allen, P. D. / Asche, C. V. et al. | 2012
-
PCN145 Treatment Patterns and Outcomes Among Patients With Unresectable Stage III or Stage IV Melanoma in MexicoSilva, A. / Lá / zaro-Leó / n, M. / de la peñ / a, R. / Frausto, P. / Vargas-Valencia, J. J. / Gó / mez-Roel, X. et al. | 2012
-
PIN2 Safety and Efficacy of RV1 and RV5 Rotavirus VaccinesBergman, H. / Soares-weiser, K. / Maclehose, H. / Cunliffe, N. / Garner, P. et al. | 2012
-
PIN4 Efficacy and Safety of the Combination Tenofovir (TDF)/Emtricitabina (FTC) + Efavirenz (EFV) in Treatment of Naive Adult Patients With HIV-1 Infection: A Systematic ReviewRizzoli, A. / Vargas, G. / Pizarro, M. / Soto Molina, H. et al. | 2012
-
PIN12 Cost Analysis of Rilpivirine Versus Efavirenz for Treatment of Human Immunodeficiency Virus (HIV)Parrett, J. / Dikun, J. / Datar, M. / Yang, Y. et al. | 2012
-
PIN15 Impact of Surgical Staphylococcus Aureus Infections on US HospitalsYu, H. / Mardekian, J. / Siu, G. / Zito, E. / Girgenti, D. et al. | 2012
-
PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 InfectionRamachandran, S. / Mahabaleshwarkar, R. / Yang, Y. et al. | 2012
-
PSS5 Assessment of the Demand and the Financial Impact of the Isotretinoin in Specialized Component of Pharmaceutical Services (CEAF) in 2011, Minas Gerais (MG), BrazilFigueiredo, A. C. / Souza, K. M. / Villela, E. / Silva, L. / Oliveira, J. / Machado, T. / Souza, A. L. / Garcia, M. / Pereira, V. et al. | 2012
-
PSS33 Comparison of the Skindex-17 Quality of Life Questionnaire with the Skindex-29 in a Large Sample of Dermatological OutpatientsSampogna, F. / Spagnoli, A. / Di Pietro, C. / Pagliarello, C. / Paradisi, A. / Tabolli, S. / Abeni, D. et al. | 2012
-
PSS30 Dosing Patterns and Health Care Provider Interactions for Psoriasis Patients Treated with UstekinumabCarter, C. / Martin, S. / Smith, D. et al. | 2012
-
PMS15 Cost Analysis of Febuxostat Versus Allopurinol for Prophylaxis of Gout FlaresJackson, T. / Shah, R. et al. | 2012
-
PMS16 Cost of Tumor Necrosis Factor Blocker Per Treated Psoriatic Arthritis Patient Using Drug Utilization Data from a US Managed Care PopulationBonafede, M. / Watson, C. / Gandra, S. R. / Princic, N. / Fox, K. M. et al. | 2012
-
PMS21 Mapping Health Care Costs to Clinical Disease Activity Where Cost Data is Lacking – A Novel Approach Using Medical Expenditure Panel Survey Data with the Corrona Rheumatoid Arthritis Disease RegistryIngham, M. / Ghushchyan, V. H. / Reed, G. / Decktor, D. / Bolce, R. / Bolge, S. / Nair, K. V. et al. | 2012
-
PMS23 Cost Per Treated Rheumatoid Arthritis (RA) Patient for Etanercept, Adalimumab and Infliximab: A Retrospective Claims Database AnalysisBonafede, M. / Gandra, S. R. / Watson, C. / Princic, N. / Fox, K. M. et al. | 2012
-
PMS42 Observed Dosing and Refill Compliance in Psoriatic Arthritis Patients Treated with GolimumabEllis, L. / Haas, S. / Tandon, N. et al. | 2012
-
PMS43 Intentional and Unintentional Non-Adherence and Patient Characteristics Associated with Treatment in Rheumatoid Arthritis PatientsGoren, A. / Vietri, J. / Madi, O. et al. | 2012
-
PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism: Analysis Based on Patient Reported Outcomes from 3 Phase III Clinical Trials of GolimumabHan, C. / Keystone, E. / Fleischmann, R. / Smolen, J. S. / Emery, P. / Genovese, M. / Doyle, M. / Hsia, E. et al. | 2012
-
PMS73 A Systematic Literature Review of Economic Studies and a Cost Analysis Related to Epidural Steroid Injections in the ElderlyBresnahan, B. / Rundell, S. / Friedly, J. / Jarvik, J. / Sullivan, S. D. et al. | 2012
-
PMS74 Developing and Implementing Patient-Resource Use Diaries for a Clinical Trial Assessing Spinal Stenosis Interventions in the ElderlyBresnahan, B. W. / Rundell, S. / Comstock, B. / Sullivan, S. D. / Jarvik, J. G. / Nguyen, H. / Bauer, Z. / Friedly, J. et al. | 2012
-
PMS75 Annual Golimumab Utilization and Costs for Psoriatic Arthritis Patients Enrolled in Managed Care PlansCarter, C. / Smith, D. / Tandon, N. et al. | 2012
-
PMS79 Patient Characteristics and Golimumab Utilization in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis PatientsTandon, N. / Haas, S. / Bolge, S. / Gunnarsson, C. et al. | 2012
-
PRS9 Waterpipe Smoking among University Students in the United States: Predictors of an Intention to QuitWu, I. H. / Rajan, S. S. / Peters, R. J. / Essien, E. J. / Abughosh, S. et al. | 2012
-
PRS33 The Effect of Adherence to Combination Therapy of Long Acting Beta Agonist and Inhaled Corticosteroid (Laba + Ics) on Emergency Department (Ed) Utilization in Newly Diagnosed Asthma PatientsChung, J. / Nichol, M. B. et al. | 2012
-
PMD7 Long-Term Clinical Outcomes After Coronary Bare-Metal and Drug-Eluting StentingYin, S. / Parente, A. K. / Teigland, C. / Jones, B. T. / Wang, R. H. et al. | 2012
-
PMD57 New Approaches for Graphing Probabilistic Patient-Relevant Health Outcomes: The Case of Renal Denervation for Resistant HypertensionGeisler, B. P. / Cohen, J. T. / Neumann, P. J. / Pietzsch, J. B. et al. | 2012
-
PSU4 Open Versus Endovascular Repair for Abdominal Aortic Aneurysm: An Exploration with Discharge and Post-Discharge-Mortality DataMark, T. / Steiner, C. / Lawrence, W. / Coffey, R. / Chu, B. C. / Kenney, T. / Nagamine, M. / Zheng, D. et al. | 2012
-
PSU16 Retrospective Analysis of Cost Outcomes for Patients Receiving Infuse Bone Graft (rhBMP-2) or Actifuse Bone Graft Substitute (Si-CaP) During Posterolateral Spinal FusionMagee, G. / Boatright, A. / Hagerman, E. / Baumer, D. / Krishnan, S. et al. | 2012
-
PSU39 Identification of Bariatric Surgical Procedures, Comorbidities and Adverse Events in Payor DataHatoum, I. J. / Hunter, T. D. / Francis, D. M. / Steinbuch, M. / Kaplan, L. M. et al. | 2012
-
PMH31 The Cost of a Schizophrenia Relapse in the Brazilian Private Health Care SystemBahmdouni, L. S. / Pereira, M. L. / Ferreira, C. N. / Santana, C. F. / Salles, G. R. et al. | 2012
-
PMH32 Impact of Second Generation Anti-Psychotics in Bipolar Patients and Schizophrenia Patients in Th California Medicaid ProgramMcCombs, J. / Jiang, Y. et al. | 2012
-
PMH75 Utilization of Prescription Sedative Hypnotics in Patients with and Without Insomnia DiagnosisWallace, L. E. / Kadakia, A. et al. | 2012
-
PSY3 Adverse Events Associated With Anti-TNF-Alpha- Agents: A Pharmacovigilance StudyDahlquist, J. E. / Guo, J. J. / Sietsema, W. / Sarangdhar, M. / Wigle, P. / Aronow, B. et al. | 2012
-
PSY20 Costs Associated With the Burden of Joint Pain in Hemophilia A and B Patients With and Without InhibitorsCyaniuk, A. / Smith, C. / Upadhyay, A. / Swallow, E. / Cooper, D. / Wisniewski, T. et al. | 2012
-
PSY31 Economic Evaluation of Eletriptan 40mg for Migraine Therapy in KoreaKim, H. J. / Oh, J. J. / Park, H. J. / Ko, S. K. et al. | 2012
-
PSY36 Economic Evaluation of Pegvisomant for Active Acromegaly Patients who Failed Available Therapies in Brazil – Public Health Care System PerspectiveFujii, R. K. / Mould, J. F. / Fernandes, R. A. / Furlan, F. / Manfrin, D. F. et al. | 2012
-
PSY51 Use of Narcotic Medications Among a Large Commercially-Insured Population in the United StatesTian, Y. / Henderson, R. R. / Frazee, S. G. et al. | 2012
-
PSY67 Psychometric Validation of the Pain Impact Questionnaire Revised With a 1-Week RecallMiller, K. / Smith, K. J. et al. | 2012
-
PCV17 Association of Adherence to Colesevelam HCI and Risk of Major Cardiovascular EventsYe, X. / Qian, C. / Li, T. et al. | 2012
-
PCV40 Evaluating Health Care Utiliization and Costs Associated with Blood Pressure Control in Patients with Newly Treated HypertensionCheng, I. N. / Flicker, W. / Shinmoto, M. / Pulicharam veettil, J. / Wong, K. et al. | 2012
-
PCV46 Assessing the Cost-Effectiveness of the Recommended Antihypertensive Drug Classes in France Using a Lifetime Markov ModelGerlier, L. / Midy, F. / Liè / vre, M. / Cohn, E. / Vellopoulou, K. / Maurel, F. / Lamotte, M. et al. | 2012
-
PCV53 A Cost-Effectiveness Analysis Comparing Dabigatran and Standard Treatment for Stroke Prevention in Atrial Fibrillation in SlovakiaPsenkova, M. / Mackovicova, S. / Tomek, D. / Bielik, J. / Spitzerova, H. et al. | 2012
-
PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF): Russian Payer PerspectiveBelousov, Y. B. / Mareev, V. Y. / Belousov, D. Y. / Afanasieva, E. V. / Ashikhmin, Y. I. / Ustyugova, A. V. et al. | 2012
-
PCV64 Health Care Resource Utilization and Costs for Acromegaly: A Retrospective Study in a Large Claims Database in the United StatesBurton, T. M. / Le nestour, E. / Bancroft, T. / Di donato, F. A. / Neary, M. et al. | 2012
-
PCV82 the Burden: A New Approach to Evaluating Venous InsufficiencyTaieb, C. et al. | 2012
-
PCV84 A Comparison of Clinician and Patient Views on Symptoms and Impact of Post-Stroke SpasticityAtkinson, M. J. / Gillard, P. / Dunning, K. / D' / Ambrosio, L. / Varon, S. F. / Zorowitz, R. D. / Kissela, B. et al. | 2012
-
PCV85 Effect of Secondary Preventive Measures on the Health Related Quality of Life of Myocardial Infarction PatientsShah, J. / Aparasu, R. R. / Birtcher, K. K. / Johnson, M. L. et al. | 2012
-
PCV87 Impact of an Interactive Care Plan on Patient Activation in Heart Failure InpatientsComer, D. / Wright, D. / Southerton, J. / Couto, J. et al. | 2012
-
CN1 Statins and Colorectal Cancer: Is There a Link?Clancy, Z. A. / Keith, S. W. / Rabinowitz, C. / Gagne, J. / Maio, V. et al. | 2012
-
CO3 Minimizing the Costs of Analyzing the Value of Health ResearchHoomans, T. / Seidenfeld, J. / Meltzer, D. et al. | 2012
-
ME4 Perioperative Outcomes, Complications, and Costs Associated With Lumbar Spinal Fusion in Older Patients With Spinal Stenosis and Spondylolisthesis: Analysis of the United States Medicare Claims DatabaseAuerbach, J. D. / Ong, K. L. / Lau, E. / Ochoa, J. / Schmier, J. K. / Zigler, J. D. et al. | 2012
-
ME3 A Policy Evaluation of Instituting Patient Navigation Program in Medicare: Does it Work for Lung Cancer PatientsShih, Y. C. / Chien, C. R. / Moguel, M. R. / Hernandez, M. / Hajek, R. / Jones, L. et al. | 2012
-
RM4 A Systematic Review of Costs Associated With Prescription Opioid RisksCangelosi, M. J. / Saunders, T. / Neumann, P. J. / Cohen, J. T. et al. | 2012
-
SB2 Comparative Effectiveness of On-Pump and Off-Pump Coronary Artery Bypass Grafting Among Elderly Patients – a Retrospective Analysis of Medicare Claims DataDatar, M. / Yang, Y. / Mahabaleshwarkar, R. / Bentley, J. P. / Banahan, B. F. et al. | 2012
-
CE4 A Framework for Stakeholder Engagement in Comparative Effectiveness ResearchLavallee, D. M. / Desai, P. J. / Mullins, C. D. / Deverka, P. A. et al. | 2012
-
CV4 Grace Risk Prediction Index, Charlson Comorbidity Index, or Both, to Predict Outcomes Associated With Acute Coronary SyndromeErickson, S. / Eagle, K. A. / Kline-rogers, E. et al. | 2012
-
PR3 Qualitative Assessment of Health-Related Productivity InstrumentsTundia, N. L. / Heaton, P. C. / Kelton, C. M. / Hass, S. / Fuldeore, M. et al. | 2012
-
UT2 Impact of 2009-2011 Global Health Care Reforms on Pricing, Access and Health Outcomes StrategyAggarwal, S. et al. | 2012
-
PHP17 Nation-Wide Survey of Patients' Attitude Toward Low Price MedicineKang, H. A. / Park, C. M. / Jang, S. M. et al. | 2012
-
PHP18 The Impact of Patent Expiries on Future Drug Spending in CanadaHunt, J. / Gaucher, M. et al. | 2012
-
PHP19 Longitudinal Analysis of Ustekinumab Dosing in Patients With or Without Prior Biologic Experience in the Wolters Kluwer Source® LX National Health Claims DatabaseCarter, C. / Haas, S. / Gunnarsson, C. / Martin, S. et al. | 2012
-
PHP22 Exploration of Claims-Based Utilization Measures for Detecting Non-Medical Use of Prescription DrugsBirt, J. / Classi, P. / Johnston, J. A. / Xie, J. / Zagar, A. et al. | 2012
-
PHP23 Savings Through the Increased Use of Generic Medicines by Elderly: The Belgian CaseDylst, P. / Vulto, A. / Simoens, S. et al. | 2012
-
PHP36 Comprehensive Value Estimation of Adalimumab-Based Treatments: Covet StudyMennini, F. S. / Marcellusi, A. / Gitto, L. / Giannantoni, P. / Favato, G. et al. | 2012
-
PHP54 Health Care Efficiency From Electronic Health Records Implementation: A Preliminary Review of the LiteratureMann, R. / Anastassopoulos, K. P. / Tran, D. / Ackerman, S. J. et al. | 2012
-
PHP60 Outcomes of Integrated Medical Care Service Provided in Outpatient Units in a Medical Center: Two-Year ExperienceLin, H. W. / Lin, C. H. / Chang, C. K. / Yu, I. W. / Chang, L. Y. / Wu, H. C. / Hsieh, Y. W. / Hung, J. S. / Cho, D. Y. et al. | 2012
-
PHP95 Prescription Monitoring Program Effectiveness: Perceptions of Drug Diversion InvestigatorsPerin, N. R. / Freeman, T. / Talbert, J. / Blumenschein, K. et al. | 2012
-
PCV109 Statin Prescribing in Northern Ireland and England Pre and Post Introduction of the Quality and Outcomes FrameworkAlabbadi, I. / Crealey, G. / Turner, K. / Rafferty, T. / Keenan, L. / Murray, P. / Mcelnay, J. et al. | 2012
-
PCV121 Using International HTA Guidelines to Inform UK Health Care Decision-Making: A Case Study of Ticagrelor in Combination with Low-Dose Aspirin for the Treatment of Acute Coronary SyndromesDequen, P. / Sutton, A. J. / McGrath, C. / Abrams, K. et al. | 2012
-
PGI1 Impact of Postsurgical Opioid Use and Ileus on Economic Outcomes in Gastrointestinal SurgeriesOderda, G. / Robinson, S. B. / Gan, T. J. / Scranton, R. / Pepin, J. / Ramamoorthy, S. et al. | 2012
-
PGI18 Societal Burden in Hepatits C Patients: The Come Study ResultsCiampichini, R. / Scalone, L. / Fagiuoli, S. / Fusco, F. / Gaeta, L. / Del prete, A. / Gardini, I. / Mantovani, L. G. et al. | 2012
-
PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I InfectionFonseca, M. / Tannus, G. / Parisi, E. et al. | 2012
-
PGI28 Proton Pump Inhibitor (Ppi) Prescribing Patterns, Ppi Costs, and Resource Utilization in a Nationally Representative Sample of Patients with Gastroesophageal Reflux Disease (GERD)Solem, C. T. / Mody, R. R. / Stephens, J. M. / Macahilig, C. / Yu, S. / Gao, X. et al. | 2012
-
PND3 Indirect Treatment Comparison (ITC) Analysis of Therapies That are Often Considered for Treatment-Experienced Patients With Relapsing-Remitting Multiple SclerosisAllen, F. L. / Osei-assibey, G. / Arnold, R. / Deniz, B. et al. | 2012
-
PND18 Cost- Effectiveness of Fingolimod on Patients With Multiple Sclerosis at the Public Mexican Health Care SystemSoria-Cedillo, I. F. / Baca-Muro, V. / Garcí / a-Conde, L. / Lemus-Carmona, E. et al. | 2012
-
PND36 Structured Benefit-Risk Assessment of Triptan Treatments Using Patient-Preference DataGonzalez, J. M. / Hauber, A. B. / Levitan, B. / Coplan, P. et al. | 2012
-
PND39 What is the Influence on Clinical Research of the EMA Guideline on Medicinal Products for the Treatment of Alzheimer's Disease?Caron, M. / Acquadro, C. / Emery, M. P. et al. | 2012
-
PND50 The Impact of Patient Age on Patterns of Diagnosis and Treatment Among Patients With Parkinson's DiseaseGrubb, E. / Lage, M. J. et al. | 2012
-
PND51 The Impact of Patient Sex on Patterns of Diagnosis and Treatment Among Patients With Parkinson's DiseaseGrubb, E. / Lage, M. J. et al. | 2012
-
PND53 Discrepancies in Hospitalization Trends by Epilepsy Among Three Latin America CountriesSoares, C. / Viana, K. P. / Santana, P. K. / Figueiredo, D. / Machado, M. et al. | 2012
-
PUK25 Role of Health Literacy on Kidney Transplant Patients Immunosuppressant Drugs Information NeedsCampbell, M. L. / Pradel, F. G. / Mullins, C. D. / Bradley-baker, L. / Hurley, H. / Cooper, M. et al. | 2012
-
PUK33 Cost-Utility Analysis of Alternative Treatments for Moderate Grade Vesicoureteral RefluxQureshi, Z. / Bennett, C. et al. | 2012
-
PRM15 Use of Centralized National Data to Estimate Costs of EPI at National Level. The Bolivian Case, 2007-2009Castañ / eda-Orjuela, C. A. / Alvis, N. / Pastor, D. / Valdes, W. / De la Hoz-Restrepo, F. et al. | 2012
-
PRM26 Access to Real-World Databases in Europe – How to Find the One That Will Answer Your Research Question?Zawaneh, Y. Z. / Cummins, G. / Van engen, A. et al. | 2012
-
PRM30 A Model to Predict Risk of Non-Adherence to Medications Highlighted in CMS Star-RatingsSulzicki, M. / Atkins, D. / Brooks, L. / Upadhyay, A. / Schilling, C. et al. | 2012
-
PRM36 International Comparisons of EQ-5D Health-States ValuationsGarcia-Molina, M. / Chicaiza, L. / Rincon, C. J. / Romano, G. et al. | 2012
-
PRM41 Translation and Cultural Adaptation of the Language Development SurveyGriffin, A. / Wild, D. / Rescorla, L. / Sunderaju, R. et al. | 2012
-
PRM45 Network Meta-Analysis of Studies with Outcomes at Multiple Time Points Using Fractional PolynomialsVieira da Silva, M. C. / Jansen, J. P. et al. | 2012
-
PRM64 Societal Perspective in Economic Evaluation: Confusions and HIRA'S RecommendationBae, S. / Lee, S. / You, M. Y. et al. | 2012
-
PDB9 Cost-Effectiveness Analysis of Saxagliptin in the Treatment of Type 2 Diabetes Mellitus in RussiaArinina, E. E. / Rashyd, M. et al. | 2012
-
PDB10 A Meta-Analysis of Efficacy and Safety of Dipeptidyl Peptidase-4 [Dpp-4] Inhibitors in Type 2 DiabetesPark, H. / Park, C. / Kim, Y. / Rascati, K. L. et al. | 2012
-
PDB40 Economic Burden of Type 2 Diabetes Mellitus in ChinaZheng, Y. / Wu, E. Q. / Xie, K. / Zheng, B. / Yang, H. Y. / Xie, J. / Wu, J. et al. | 2012
-
PDB61 The Burden of Diabetes Mellitus for Medicare BeneficiariesCostantino, M. E. / Stacy, J. N. / Song, F. / Xu, Y. / Bouchard, J. R. et al. | 2012
-
PDB76 Gap Analysis of Existing Diabetes-Specific Health-Related Quality of Life Measures for Use Among Multi-Ethnic English-Speaking Asians With Diabetes: An Interim AnalysisKoh, O. / Lee, J. / Goh, S. Y. / Thumboo, J. / Cheung, Y. B. / Tai, E. S. / Singh, A. / Wee, H. L. et al. | 2012
-
PDB95 A Descriptive Study of Opioid Use in the Management of Diabetic Peripheral Neuropathy (DPN) in a Large Commercially Insured PopulationPatil, P. / Said, Q. / Thomas, J. / Wolfe, J. / Martin, B. et al. | 2012
-
PIH6 Antipsychotic Use and Risk of Nursing Home Admission among Community-Dwelling Dual Eligible BeneficiariesAparasu, R. R. / Chatterjee, S. et al. | 2012
-
PIH32 Demographic and Health Characteristics Associated with Intentional and Unintentional Non-Adherence among Costly Chronic Conditions in the United StatesGoren, A. / Gupta, S. / Dibonaventura, M. D. et al. | 2012
-
PIH74 Disparities on Maternal Mortality among Colombian Regions in 2000, 2005 and 2008Sandoval Vargas, G. / Amaya, A. C. / Peralta Pizza, F. / Velasquez, D. / Eslava Schmalbach, J. H. et al. | 2012
-
PCN11 Systemic Therapy for Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in Nationally Representative Claims Database in the United StatesValluri, S. / Seal, B. / Ramsey, S. / Sullivan, S. D. / Shermock, K. / Sarma, S. / Kreilick, C. / Foltz-Boklage, S. et al. | 2012
-
PCN43 Economic Burden of Hepatocellular Carcinoma in ChinaWu, E. Q. / Wu, J. / Yang, H. Y. / Zheng, Y. / Xie, K. / Yu, R. / Xie, J. et al. | 2012
-
PCN70 Cost Effectiveness Analysis Based on Progression Free Survival (PFS) of Pazopanib Versus Sunitinib for the Treatment of Advanced Renal Cell Carcinoma (ARCC) in the Mexican ContextAnaya, P. / Delea, T. E. / Pichardo, P. / Diaz, J. R. et al. | 2012
-
PCN73 Economic Evaluation of Antithrombotic Therapies in Patients With Cancer in MexicoMuciñ / o-Ortega, E. / Gutié / rrez-Colí / n, C. I. / Galindo-Suá / rez, R. M. et al. | 2012
-
PCN81 Health Related Quality of Life, Direct Medical, Non-Medical, and Indirect Cost Analysis of Stage Iii Colorectal Cancer Patients Receiving Different Adjuvant Chemotherapy Treatments in TaiwanChen, H. H. / Chen, W. T. / Lee, H. H. / Lin, J. K. / Chou, Y. H. / Yang, M. C. / Tan, E. C. / Lin, E. I. et al. | 2012
-
PCN91 Consumption of Antineoplastic Agents in the Slovak Republic Within the Period of 2008-2011Gatialová / K. / Bellova, K. / Foltan, V. / Majtá / s, J. et al. | 2012
-
PCN115 Patterns of Care in Patients With Myelodysplastic Syndromes Treated With Hypomethylating AgentsFaria, C. / Chang, E. / Powers, A. / Cherepanov, D. / Broder, M. et al. | 2012
-
PCN125 Predictors of Methotrexate Containing Chemotherapy in Women Diagnosed With Early Stage Breast CancerKadakia, A. / Rajan, S. S. / Du, X. L. / Johnson, M. L. et al. | 2012
-
PCN129 Association Between BMI and Personal Health and Screening History, Preventive Care, and Wellness Behaviors Among Participants in a Mobile Mammography ProgramAtkins, E. / Madhavan, S. / LeMasters, T. / Vyas, A. / Vona-Davis, L. / Kennedy, S. / Remick, S. et al. | 2012
-
PIN46 The Effect of Anemia on Health Status and Work Productivity Among Treated Hepatitis C PatientsDiBonaventura, M. D. / Gross, H. / Wagner, J. S. et al. | 2012
-
PIN55 Anti-Malarial Drugs Management in Public and Private Secondary Health Care Facilities: A Comparative Cross Sectional Study from PakistanMalik, M. / Hassali, M. A. / Shafie, A. / Hussain, A. et al. | 2012
-
PIN68 Impact of At-Risk Window Assignment on Retrospectively-Estimated Incidence and Costs of Safety and Tolerability Among Medicaid HIV Patients Initiating Protease Inhibitor-Based Combination Antiretroviral Therapy in the United StatesJohnston, S. S. / Juday, T. / Espindle, D. / Chu, B. C. / Hebden, T. et al. | 2012
-
PSS20 Comparative Study of the Performances of Generic and Disease-Specific Measures in Cataract PatientsSuh, J. K. / Doctor, J. et al. | 2012
-
PMS11 The Cost of Hospitalization of Hip Osteoarthritis Patients in France in 2010Taieb, C. et al. | 2012
-
PMS30 Cost-Effectiveness of Bisphosphonates in Reducing Hip Fractures in the United StatesToliver, J. / Blanchette, C. M. et al. | 2012
-
PMS77 Medication Usage Pattern of Newly Diagnosed Rheumatoid Arthritis (RA) Patients - A Three-Year Follow-Up StudyChen, C. Y. / Wright, D. / Hagen, S. / Naim, A. / Edington, D. et al. | 2012
-
PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological ShortcomingsThorlund, K. / Mills, E. et al. | 2012
-
PND13 Economic Burden of Lennox-Gastaut SyndromeSwindle, J. P. / Song, R. / Liu, F. / Adams, S. et al. | 2012
-
PRS22 Cost-Effectiveness of Indacaterol on Patients with Chronic Obstructive Pulmonary Disease (Copd) at the Public Mexican Health Care SystemReyes-lopez, A. / Lemus-carmona, E. A. / Orozco, E. et al. | 2012
-
PRS27 Cost-Utility Analysis of Omalizumab Compared with Standard Therapy in Patients Over Twelve Years Old with Severe Asthma from the Colombian Health System PerspectiveAriza, J. G. / Acosta, T. / Pinzon, J. F. et al. | 2012
-
PRS45 A Large-Scale Retrospective Study of Emergency Department Visits or Hospitalizations for Anaphylaxis among Patients with Employer- Sponsored Health InsuranceLandsman-blumberg, P. / Wei, W. / Douglas, D. / Smith, D. M. / Camargo, C. A. et al. | 2012
-
PRS52 The Stability of Additive Treatment Effects in Multiple Treatment Comparison Meta-Analysis: a Simulation StudyThorlund, K. / Mills, E. et al. | 2012
-
PMD1 Historical Trends in Outcomes Following Aortic and Mitral Heart Valve Replacement Procedures: A Population-Based Study of 29,582 Medicare Patients from 1997 to 2009Ong, K. L. / Patel, J. / Watson, H. / Helmus, M. / Kuehn, C. / Ochoa, J. et al. | 2012
-
PMD6 The Clinical Usefulness of CT Coronary Angiography for the Diagnosis of Ischemic Heart Disease in Patients with Chest PainJang, E. J. / Lee, H. J. / Kim, Y. J. / Park, S. / Song, H. / Cha, M. J. / Shim, J. I. / Choi, J. E. / Ahn, J. et al. | 2012
-
PMD8 Efficacy of Systemic Hyperbaric Oxygen Therapy for Non-Healing Diabetic Ulcers of the Lower Limb: Systematic Review and Meta-AnalysisO'Reilly, D. / Campbell, K. / Burke, N. / Assasi, N. / Bowen, J. / Tarride, J. E. / Goeree, R. et al. | 2012
-
PMD14 Estimating the Economic Burden of Atrial Fibrillation in Selected Developing CountriesRizzo, J. A. / Mallow, P. / Waters, H. / Cirrincione, A. et al. | 2012
-
PMD36 The Use of Chlorhexidine Gluconate Impregnated Sponge Dressings to Prevent Central-Line Associated Bloodstream Infections and Local Site Infections in Canadian Hospitals: An Economic AnalysisGoldstein, L. J. et al. | 2012
-
PMD59 Assessment of Administrative Data for Evaluating the Shifting Acquisition of Clostridium Difficile Infection in EnglandJen, M. H. et al. | 2012
-
PSU15 Impact of Complications in Solid Organ Transplants on Hospital Charges and Length of StayJensen, I. S. / Helm, T. / Cyr, P. L. et al. | 2012
-
PSU23 An Economic Evaluation of Thoracoscopic Pleural Abrasion and Thoracoscopic Talcage as Treatment Choices for Pneumothorax in Cystic Fibrosis PatientsYeola, D. C. / Sansgiry, S. S. et al. | 2012
-
PMH13 A Real-World Us Retrospective Database Analysis Evaluating Treatment Patterns, Health Care Resource Utilization and Costs in Patients with Bipolar Disorder Newly Treated with Immediate Release (IR) or Extended Release (XR) Quetiapine FumarateLocklear, J. C. / Alemayehu, B. / Brody, R. S. / Chavoshi, S. / Tunceli, O. / Kern, D. / Earley, W. R. et al. | 2012
-
PMH17 Obesity and Risk of Depression/Anxiety in Children and Adolescents: A Medical Expenditure Panel Survey StudyBhattacharya, R. / Aparasu, R. R. / Rajan, S. S. / Chen, H. et al. | 2012
-
PMH23 Impact of Refill and Save Program on Adherence to Desvenlafaxine and Extended Release Venlafaxine HClShah, S. / Buikema, A. / Trocio, J. / Alvir, J. / Odell, K. / Hulbert, E. / Halpern, R. / Whiteley, J. et al. | 2012
-
PMH25 Cost and Use of Resources in Patients with Schizophrenia and Bipolar Disorder Switching from Immediate Release Quetiapine (QTP-IR) to Extended Release Quetiapine (QTP-XR) in Italy- the IBIS StudyDegli Esposti, L. / La Tour, F. / Mencacci, C. / Montagnani, G. / Pasina, C. / Sangiorgi, D. / Spina, E. et al. | 2012
-
PMH36 An Economic Evaluation of Screening for Dementia in South KoreaYu, S. Y. / Jang, S. H. / Lee, T. J. et al. | 2012
-
PMH57 Cross-Country Comparisons of Adults with Major Depressive DisorderAnnunziata, K. / Gross, H. J. / Chapnick, J. et al. | 2012
-
PMH69 Depression Treatment and Short-Term Health Care Expenditures among Elderly Medicare Beneficiaries with Chronic IllnessShah, N. / Shen, C. / Findley, P. / Sambamoorthi, U. et al. | 2012
-
PMH79 Medical Costs and Hospitalizations among Persons with Depression Treated with Adjunctive Atypical Antipsychotic TherapyHalpern, R. / Kalsekar, I. / Nadkarni, A. / Nguyen, H. / Song, R. / Forbes, A. / Nelson, J. C. et al. | 2012
-
PSY10 Incidence and Prevalence of Idiopathic Inflammatory Myopathies Among Commercially Insured, Medicare Supplemental Insured, and Medicaid Enrolled PopulationsTomic, K. S. / Amato, A. A. / Fernandes, A. et al. | 2012
-
PSY25 Health Care Resource Utilization (HRU) and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus (SLE) in a Medicaid Population in the United StatesKan, H. / Song, X. / Bechtel, B. / Johnson, B. H. / O' / Sullivan, D. / Molta, C. T. et al. | 2012
-
PSY26 Costs and Outcomes of Patients With Haemophilia a (HA) and Factor VIII Inhibitors Treatment: The Immune Tolerance and Economics Retrospective Registry (ITER) ResultsGringeri, A. / Scalone, L. / Cortesi, P. A. / Rocino, A. / Mantovani, L. G. et al. | 2012
-
PSY27 Cost Effectiveness of Treatment With Etanercept or Ustekinumab for Moderate to Severe PsoriasisVillacorta, R. / Hay, J. / Messali, A. et al. | 2012
-
PSY34 Assessing Interventions for Adults With Metabolic Syndrome: A Comprehensive Economic Markov Decision ModelCastro, M. / Dequen, P. / Davies, M. J. / Khunti, K. / Abrams, K. R. et al. | 2012
-
PSY33 Adaptation to Colombia and Venezuela of the Economic Model Dasatinib First-Line Treatment of Chronic Myeloid Leukemia, Developed by the York Health Economics ConsortiumOrozco, J. J. / Valencia, J. E. et al. | 2012
-
PSY43 Patient Perspectives on Perceived Value of Treatments for Moderate-to-Severe PsoriasisNaim, A. / Gollins, J. R. / Chen, W. / Walls, D. et al. | 2012
-
PSY42 Patient-Reported Outcome (PRO) Instrument for Detection of Peripheral Neuropathy (PN) in Patients With Multiple Myeloma (MM): The FACT/GOG-NtxChoi, S. / Neuwirth, R. / Cakana, A. / San miguel, J. F. / Richardson, P. G. et al. | 2012
-
PSY44 Examining Disease and Patient Characteristics of Individuals With Moderate-to-Severe Psoriasis in a Nationally Representative Population in the United StatesNaim, A. / Gollins, J. R. / Chen, W. / Walls, D. et al. | 2012
-
PSY59 Variation in Health-Related Quality of Life Associated With Changes in Transfusion Status of Patients With Myelodysplastic Syndromes Across Six Months of Treatment With AzacitidinePashos, C. L. / Grinblatt, D. L. / Sekeres, M. A. / Komrokji, R. S. / Narang, M. / Swern, A. S. / Street, T. K. / Sullivan, K. A. / Harding, G. / Khan, Z. M. et al. | 2012
-
PSY68 Preferences for Immunoglobulin Treatment Administration Attributes by Patients and ParentsMohamed, A. / Kilambi, V. / Luo, M. / Li-McLeod, J. et al. | 2012
-
PCV88 Evaluating Outcomes Related to Hypertension in Toledo-Lucas County Carenet PatientsPartha, G. / Holiday-Goodman, M. / Pinto, S. / Mauro, V. et al. | 2012
-
Editorial Board| 2012
-
CO1 Individual Decisions and Social Value: A Conceptual Framework to Explore Alternative Decision Making Approaches and the Value of Heterogeneity in the Era of Individualized CareEspinoza, M. A. / Manca, A. / Sculpher, M. J. / Claxton, K. et al. | 2012
-
MO1 New Concepts in Discrete Choice Preference Measurement: An Application to Drug Treatment for Juvenile Idiopathic ArthritisRegier, D. A. / Burnett, H. F. / Ungar, W. et al. | 2012
-
IN2 Comparative Efficacy at 48 Weeks of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Treatment Naive Hiv-1 Patients: A Matching Adjusted Indirect Comparison of Randomized TrialsXie, J. / Juday, T. / Swallow, E. / Du, X. / Uy, J. / Hebden, T. / Signorovitch, J. et al. | 2012
-
IN3 Translating Outcomes from a Dynamic Transmission Model for Varicella Vaccination to Cost-Effectiveness Estimates: The Impact of Different Analytic Approaches on the ResultsThompson, J. R. / Talbird, S. E. / Mauskopf, J. A. / Brogan, A. / Standaert, B. et al. | 2012
-
IN4 Health Care Resource Utilization (HCRU) and Costs among Patients Treated for Nosocomial Pneumonia (NP) Caused by Methicillin Resistant Staphylococcus Aureus (Mrsa): Secondary Analysis of a Multi-Center Randomized Controlled StudySolem, C. T. / Niederman, M. S. / Chastre, J. / Wan, Y. / Gao, X. / Myers, D. E. / Haider, S. / Chambers, R. / Li, J. Z. / Van hout, B. A. et al. | 2012
-
PHP1 Establishing Principles and Indicators for Collaborative Research (EPIC): Results of Pilot WorkKupferschmidt, B. S. / Lavallee, D. M. / Tambor, E. S. / Desai, P. J. / Tunis, S. R. / Deverka, P. A. et al. | 2012
-
PHP5 Innovative Methods for Stakeholder Engagement: An Environmental ScanMallery, C. / Ganachari, D. / Smeeding, L. / Fernandez, J. / Lavallee, D. / Siegel, J. / Robinson, S. / Moon, M. et al. | 2012
-
PHP12 Shortages of Systemic Antibiotics in the United States: A Public Health ConcernBalkhi, B. / Araujo-Lama, L. / Nguyen, D. / Le, P. / Seoane-Vazquez, E. / Rodriguez-Monguio, R. / Fox, E. R. / Szeinbach, S. L. et al. | 2012
-
PHP20 Factors Associated With Primary Nonadherence to Chronic and Acute MedicationsShin, J. / McCombs, J. / Sanchez, R. J. / Udall, M. / Deminski, M. C. / Cheetham, C. T. et al. | 2012
-
PHP31 Analysis of Formulary Lists for War Veterans and Chernobyl Victims in UkraineTolubaiev, V. / Zalis' / ka, O. / Mendrik, O. / Majnych, J. et al. | 2012
-
PHP43 Financing Health Care in NepalShrestha, D. L. et al. | 2012
-
PHP46 Design and Operational Challenges With Time and Motion (T&M) Studies Run Alongside Clinical TrialsDe Cock, E. / Payne, K. A. / Urspruch, A. et al. | 2012
-
PHP91 Factors Affecting Serum Potassium Measurements After Initiation of Spironolactone at an Academic Medical CenterLin, F. J. / Moja, J. B. / Galanter, W. L. / Lambert, B. L. et al. | 2012
-
PHP100 Defining Elements of Value for Rare Disease TreatmentsHutchings, A. / Ethgen, O. / Schmitt, C. / Rollet, P. et al. | 2012
-
PHP102 From Value to Price: What Should Be the Path for Orphan Drugs?Ethgen, O. / Hutchings, A. / Rollet, P. / Standaert, B. et al. | 2012
-
PHP106 Priority Setting for Health Technology Assessment in UkrainePariy, V. / Stepanenko, A. / Mandrik, O. / Zalis' / ka, O. et al. | 2012
-
PHP109 Differentatiator for the Future: Health Technology Environmental FootprintsWright, A. J. / Froehlich, H. J. et al. | 2012
-
PCV104 Analysis of ARB and ACEI Consumption, Budget and Price Chance in Years for TurkeyKockaya, G. / Wertheimer, A. / Vural, M. / Akbulat, A. / Artı / ran, G. / Kerman, S. et al. | 2012
-
PCV103 Vip Brazil: Resource Use and Associated Costs of Thrombotic Events After Total Knee Replacement (TKR) Surgery in Brazilian Public Health Care System (SUS)Nita, M. E. / Comparini, L. B. / Mainine, S. / Santinho, C. S. / Fujii, R. K. / Mussolino, F. / Rached, R. / Rahal, E. et al. | 2012
-
PCV112 The Focus on Cardiovascular Drugs in Works of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011 As an Example of a Light Touch HTA AgencyOfierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. / Pasierski, T. et al. | 2012
-
PGI19 Societal Burden in Hepatits B Patients: The Come Study ResultsMantovani, L. G. / Fusco, F. / Ciampichini, R. / Fagiuoli, S. / Gardini, I. / Gaeta, L. / Del prete, A. / Scalone, L. et al. | 2012
-
PND4 Trends of Z-Drugs Prescriptions in Taiwanese Adult PopulationsYu, I. W. / Lin, H. W. / Liao, C. H. / Chou, C. H. / Wu, M. P. et al. | 2012
-
PND17 Economic Value of Screening for Early Parkinson's DiseaseJohnson, S. / Siderowf, A. et al. | 2012
-
PND24 A Review of Cost-Effectiveness Studies for Anti-Epileptic DrugsKhan, N. / Shah, D. / Wang, Z. / Tongbram, V. / Verdian, L. et al. | 2012
-
PND31 Assessing the Relationship Between the Number of Nursing Support Encounters and Medication Possession Ratio in Relapsing Remitting Multiple Sclerosis Patients Receiving Glatiramer AcetateJones, J. / Scheidt, D. / Kaushal, R. / Carroll, C. A. et al. | 2012
-
PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of BravoCarroll, C. A. / Oleen-Burkey, M. A. et al. | 2012
-
PND60 Identifying a Condition With No ICD-9-CM Diagnosis Code From Administrative Claims Data: Post-Stroke Patients With Pseudobulbar AffectHalpern, R. / Yonan, C. / Kulakodlu, M. et al. | 2012
-
PUK11 Examining the Dosing Patterns and Costs of Epoetin Alfa and Darbepoetin Alfa among Hospital Outpatients with Chronic Kidney Disease Not on DialysisLafeuille, M. H. / Naim, A. / Forlenza, J. B. / Laliberté / Lefebvre, P. et al. | 2012
-
PRM11 The Rise Of Budget Impact AnalysesWong, G. K. / Hamer, N. / Wilson, T. / Costello, S. et al. | 2012
-
PRM12 Comparison of Two Approaches to Costing National Immunization Programs: Central Level Budgeting Versus Detailing Costing Exercises Using a Novel Provac EPI Costing Tool in BoliviaCastañ / eda-Orjuela, C. A. / Pastor, D. / Valdes, W. / Resch, S. / Toscano, C. M. / De la Hoz-Restrepo, F. et al. | 2012
-
PRM13 Sensitivity Analysis in Cost-Effectiveness Analysis in Korea: A Review of Industry Submissions to HIRALee, S. / Bae, S. et al. | 2012
-
PRM42 Patient Preferences for Reminders in Clinical Trials: Improving Both Compliance and Patient ExperienceRoss, J. / Ross, E. et al. | 2012
-
PRM47 Bayesian Regression Models for Estimation of Illness-Attributable Cost from Aggregate DataMitsakakis, N. / Tomlinson, G. et al. | 2012
-
PRM50 Meta-Regression Models to Address Heterogeneity and Inconsistency in Network Meta-Analysis of Survival OutcomesCope, S. / Jansen, J. P. et al. | 2012
-
PRM51 Comprehensive Review of Employer-Sponsored Wellness Strategies and Their Economic and Health-Related Outcomes: Evidence Quality and Opportunities for Future ResearchKaspin, L. C. / Gorman, K. M. / Miller, R. M. et al. | 2012
-
PRM60 Operationalising Multiple Criteria Decision Analysis for Health Technology AssessmentThokala, P. et al. | 2012
-
PRM63 Closing the Gap Between the Formulation and Implementation of Clinical Practice Guidelines Based on EvidenceGordillo, A. M. / Eslava-Schmalbach, J. / Amaya Arias, A. C. et al. | 2012
-
PDB14 Assessing Treatment Success of Diabetes Therapies - Number Needed to Treat to Reach a Clinically Relevant Composite Endpoint: Using a Meta-Analysis of the Liraglutide Clinical Trial ProgramLanger, J. / Bouchard, J. R. / Ploug, U. J. et al. | 2012
-
PDB33 The Associated Costs of Treating Type 2 Diabetes Patients to a Clinically Relevant Composite Endpoint With Liraglutide Versus ExenatideLanger, J. / Bouchard, J. R. et al. | 2012
-
PDB34 Real-World Health Care Utilization, Productivity and Associated Costs Among Employees With Type 2 Diabetes Mellitus Treated With Insulin Glargine or Neutral Protamine Hagedorn (Nph) Insulin in the United StatesWang, L. / Wei, W. / Miao, R. / Xie, L. / Baser, O. et al. | 2012
-
PDB35 Evaluation of Cost Offset Associated with Tolvaptan Usage among Hyponatremic Siadh Patients in the United States, Based on the Salt-1 and Salt-2 TrialsDasta, J. F. / Chiong, J. R. / Christian, R. / Lin, J. et al. | 2012
-
PDB54 Saxagliptin or Sulfonylurea After Metformin Secondary Failure: a Cost-Effectiveness Analysis in ColombiaElgart, J. F. / Gonzalez, L. / Caporale, J. E. / Aiello, E. / Valencia, J. E. / Gagliardino, J. J. et al. | 2012
-
PIH10 Utilization Patterns of Bisphosphonates and Selective Serotonin Reuptake Inhibitors from 2004 to 2008 among Adult WomenNyandege, A. N. / Harpe, S. E. et al. | 2012
-
PIH12 Budget Impact Analysis of Adding a New Fixed-Dose Combination Therapy of Dutasteride and Tamsulosin to the Treatment of Symptomatic Benign Prostatic Hyperplasia in Quebec, CanadaIsmaila, A. / Posnett, J. / Walker, A. / Sayani, A. / Robson, R. C. / Su, Z. et al. | 2012
-
PIH21 Cost Impact Analysis of an End-of-Life Care Program for Nursing Home Residents: The Preliminary Results from Project CareTeo, K. W. / Govinda Raj, A. / Ng, C. W. / Leong, I. Y. / Heng, B. H. et al. | 2012
-
PIH31 The Impact of Reducing Dosing Frequency of Oral Therapies on Adherence, Compliance, and Cost for Acute and Chronic Illnesses: A Meta-AnalysisSrivastava, K. / Arora, A. / Kataria, A. / Cappelleri, J. C. / Sadosky, A. / Peterson, A. M. et al. | 2012
-
PIH35 Utilization and Adherence One-Year Post CDHP ImplementationAverbukh, A. N. / Matlin, O. S. / Levine, L. et al. | 2012
-
PIH53 Assessment of PRO Labels Claims Granted by the FDA as Compared to the EMADemuro, C. / Clark, M. / Coon, C. / Evans, E. / Mordin, M. / Gnanasakthy, A. et al. | 2012
-
PIH58 Mobile Phone Use in Patient Reported Outcomes - Academia and BeyondO'Gorman, H. et al. | 2012
-
PIH60 Speaking of PROs: Towards Finding a Common PROse for Improving Communication about Health-Related Quality of Life ConceptsErickson, P. / Willke, R. J. et al. | 2012
-
PIH75 Disparities in Neonatal Mortality in Colombia from 2000 to 2009Velá / squez Granados, D. / Peralta Pizza, F. / Amaya Arias, A. C. / Eslava Schmalbach, J. H. et al. | 2012
-
PIH85 The Disability and Qol with the ElderlyTazaki, M. / Yamaguchi, T. et al. | 2012
-
PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA)Matheus, W. / Duran, M. A. / Clark, O. A. / Kumar, A. / Ferreira, U. / Botrel, T. E. et al. | 2012
-
PCN17 Chemotherapy Treatment and Impact of Second Line Chemotherapy on Overall Survival (OS) in Metastatic Castrate Resistant Prostate Cancer (CRPC) in Southeastern Oncology Community PracticeSeal, B. / Sullivan, S. D. / Ramsey, S. / Kreilick, C. / Foltz-Boklage, S. / Gilmore, J. W. / Haslip, S. / Asche, C. / Shermock, K. M. / Sarma, S. et al. | 2012
-
PCN20 Analysis of Using Trastuzumab for the Treatment of Advanced Gastric Cancer With HER2 PositiveLechuga, D. / Gay, J. G. / Alva, M. / Sanchez-kobayashi, R. et al. | 2012
-
PCN56 Benchmarking Use in Economic Value Assessment of Oncologic Drugs-Example of CabacitaxelFoltanova, T. / Tainova, E. / Tomek, D. / Foltan, V. et al. | 2012
-
PCN74 Economic Evaluation of Everolimus as Second Line Treatment in Metastatic Renal Cancer in MexicoNevarez-Sida, A. / Fuentes-Alburo, A. et al. | 2012
-
PCN93 Endocrine Therapyadherence and Persistence and Survival Among Women With Breast Cancer in BrazilBrito, C. / Portela, M. C. / Vasconcellos, M. T. et al. | 2012
-
PCN97 Preference Scores for 6 Types of Cancer Using Fact and EQ-5DPickard, S. / Ray, S. / Ganguli, A. et al. | 2012
-
PCN112 Lessons Learned From HTA Cost Effectiveness Evaluations of New Castration-Resistant Prostate Cancer MedicationsMoï / se, P. / Fassler, P. / Holmstrom, S. et al. | 2012
-
PCN124 FERPAC: A Practice Survey on the Administration of IV Iron Complexes on a Central Venous Access Port in Cancer Patients in FranceRouillon, L. / Janus, N. / Rey, J. B. / Scotté / F. / Zakin, L. / Mahi, L. / Deray, G. / Launay-Vacher, V. et al. | 2012
-
PCN134 Effects of Clinical Pharmacist Interventions on Clinical Outcomes in Oncology PatientsEl-Hamamsy, M. et al. | 2012
-
PCN141 Projecting the Potential Public Health Impact of a 9-Valent HPV Vaccine in the United StatesPillsbury, M. / Kawai, K. / Nwankwo, C. / Weiss, T. / Dasbach, E. / Elbasha, E. H. et al. | 2012
-
PIN20 Costs of Probable Bacterial Pneumonia in Children Under 5 Years Old in ColombiaAlvis, N. / Orozco-Africano, J. M. / Paternina-Caicedo, A. / Coronell, W. / Jervis-Já / labe, D. / De La Hoz, F. et al. | 2012
-
PIN23 Cost of Diagnosis and Prevention of Congenital Cytomegalovirus InfectionKö / vi, R. / Heté / nyi, G. / Sikló / s, P. / Boncz, I. et al. | 2012
-
PIN26 Pharmacoeconomic Analysis of Sequential Intravenous/Peroral (I.V./P.O.) Therapy of Community-Acquired Pneumonia (CAP)Zaitsev, A. / Sinopalnikov, A. / Tyrsin, O. / Morozov, A. et al. | 2012
-
PIN28 Cost Effectiveness Analysis of Vaccination With 13-Valent (PCV13) and 23-Valent (PPSV23) Pneumococcal Vaccines for Adults in ColombiaNuñ / ez, S. M. / Mould-Quevedo, J. F. / Gutierrez-Ardila, M. V. / Roberts, C. S. / La Rotta, J. E. et al. | 2012
-
PIN60 Epidemiology of Pneumococcal Diseases in Mexico in Patients Older Than 50 Years OldEchaniz-Aviles, G. / Peniche-Otero, G. / Rodrí / guez-Abrego, G. / Gryzbowski, E. / Chi, G. / Galindo-Suá / rez, R. M. et al. | 2012
-
PSS6 Pharmacoeconomic Evaluation of Open-Angle Glaucoma Treatment in RussiaSerpik, V. G. / Kulikov, A. et al. | 2012
-
PSS19 Validation of the Paediatric Hearing Impairment Caregiver Experience (PHICE) InstrumentLim, H. Y. / Xiang, L. / Li, R. / Wong, N. / Yuen, C. P. et al. | 2012
-
PSS21 Assessing Pruritus Among Patients with Atopic Dermatitis: Targeted Literature and Instrument ReviewBrown, T. / Olanrewaju, O. / Deal, L. / Katz, E. / Chiou, C. F. / Martin, S. / Fehnel, S. et al. | 2012
-
PSS24 Patient-Reported Outcomes in a Dental Practice-Based Research Network:PEARLBotello-Harbaum, M. T. / Collie, D. / Matthews, A. G. / Vena, D. A. / Craig, R. G. / Curro, F. A. / Thompson, V. P. et al. | 2012
-
PSS26 Determining Accurate Dosing of Ustekinumab from Specialty Pharmacy DataSchmeichel-Mueller, C. / Gunnarsson, C. / Martin, S. et al. | 2012
-
PMS6 Treatment Pattern Visualization of Medicare Patients Diagnosed with Rheumatoid Arthritis and Initiating Tumor Necrosis Factor TherapyBaser, O. / Wang, L. / Xie, L. / Yuce, H. et al. | 2012
-
PMS8 Estimating Incidence and Prevalence of Osteoarthritis (OA) in Alberta Using Administrative Claims DataMarshall, D. / Enns, E. / Vanderby, S. / Frank, C. / Maxwell, C. / Wasylak, T. / Mosher, D. P. / Barnabe, C. / Noseworthy, T. et al. | 2012
-
PMS31 Cost-Effectiveness Analysis of Golimumab for the Treatment of Rheumatoid ArthritisDesai, R. J. / Rao, J. / Biddle, A. K. et al. | 2012
-
PMS20 Real Life Treatment Cost of Rheumatoid Arthritis, Psoriasis, Crohn's Disease and Ulcerative Colitis in the Brazilian Private Health Care SystemMorais, A. D. / Pereira, M. L. / Paloni, E. D. / Ferreira, C. N. / Bonachela Alves, F. et al. | 2012
-
PMS70 Tumor Necrosis Factor (TNF)-Blocker Dose Escalation among Patients with Rheumatoid Arthritis (RA) in a Large Managed Care Population in the United StatesFisher, M. / Watson, C. / Gandra, S. R. / Chen, Y. W. / Fox, K. M. et al. | 2012
-
PCV92 Drug Approval Strategies in GermanyGissel, C. et al. | 2012
-
PRS16 Economic Burden Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in ChinaYang, H. Y. / Wu, J. / Zheng, Y. / Xie, K. / Jin, L. / Xie, J. / Wu, E. Q. et al. | 2012
-
PRS38 A Survey of Asthma Management Programs in Managed Care OrganizationsComer, D. / Couto, J. / O' / Connell, K. / Goldfarb, N. et al. | 2012